0001825079Q1--12-31false0.0285http://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://velo3d.com/20250331#AccruedExpensesAndOtherLiabilitiesCurrenthttp://velo3d.com/20250331#AccruedExpensesAndOtherLiabilitiesCurrenthttp://velo3d.com/20250331#OtherLiabilitiesAndLeaseLiabilitiesNoncurrenthttp://velo3d.com/20250331#OtherLiabilitiesAndLeaseLiabilitiesNoncurrenthttp://velo3d.com/20250331#AccruedExpensesAndOtherLiabilitiesCurrenthttp://velo3d.com/20250331#AccruedExpensesAndOtherLiabilitiesCurrenthttp://velo3d.com/20250331#OtherLiabilitiesAndLeaseLiabilitiesNoncurrenthttp://velo3d.com/20250331#OtherLiabilitiesAndLeaseLiabilitiesNoncurrentP0Y00001825079vldx:BepoWarrantsMembervldx:WarrantLiabilityMember2025-03-310001825079vldx:SecuredNotesMember2025-03-310001825079vldx:ComputersAndSoftwareMember2024-12-310001825079vldx:OtherLocationsMember2024-01-012024-03-310001825079us-gaap:CommonStockMember2025-01-012025-03-310001825079us-gaap:MeasurementInputExpectedDividendRateMember2024-12-310001825079vldx:AugustInducementWarrantsMembervldx:WarrantLiabilityMember2024-12-3100018250792023-01-012023-12-310001825079vldx:BepoAgentWarrantsMembervldx:WarrantLiabilityMember2024-12-310001825079us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001825079vldx:July2024PrivateWarrantsMemberus-gaap:MeasurementInputSharePriceMember2024-12-310001825079srt:AmericasMember2025-01-012025-03-310001825079vldx:ContingentEarnoutLiabilityMember2024-03-310001825079us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:A2021EquityIncentivePlanMember2024-04-300001825079vldx:A2022PrivatePlacementWarrantsAndA2023PrivateWarrantBMember2024-12-310001825079us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-310001825079us-gaap:SalesRevenueNetMembervldx:Customer1Memberus-gaap:CustomerConcentrationRiskMember2025-01-012025-03-310001825079vldx:WarrantLiabilityMembervldx:A2023PrivateWarrantBMember2023-12-310001825079us-gaap:FairValueMeasurementsRecurringMembervldx:A2023PrivatePlacementWarrantsBMember2025-03-310001825079vldx:BepoAgentWarrantsMembervldx:WarrantLiabilityMember2024-01-012024-03-310001825079us-gaap:EmployeeStockOptionMember2024-01-012024-03-310001825079us-gaap:MeasurementInputRiskFreeInterestRateMembervldx:AugustInducementWarrantsMember2024-12-310001825079us-gaap:MeasurementInputRiskFreeInterestRateMembervldx:July2024PrivateWarrantsMember2024-12-310001825079vldx:A2022PrivatePlacementWarrantsMembervldx:WarrantLiabilityMember2024-03-310001825079us-gaap:RetainedEarningsMember2023-12-310001825079us-gaap:MeasurementInputRiskFreeInterestRateMember2025-03-310001825079us-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-03-310001825079us-gaap:CommonStockMember2023-12-3100018250792024-06-102024-06-100001825079vldx:FebruaryNoteSecondTrancheMember2024-12-310001825079vldx:SecuredNotesMember2023-08-140001825079vldx:A2024PrivateWarrantsMembervldx:WarrantLiabilityMember2025-03-310001825079vldx:BepoWarrantsMember2025-03-310001825079vldx:ATMSalesAgreementMember2025-03-310001825079vldx:AtTheMarketOfferingMember2024-12-310001825079vldx:A2024PrivateWarrantsLiabilityMemberus-gaap:MeasurementInputSharePriceMember2025-03-310001825079vldx:WarrantLiabilityMembervldx:PrivatePlacementWarrantsMember2023-12-310001825079vldx:CommonStockWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2025-03-310001825079vldx:A2023PrivateWarrantAMember2024-01-012024-12-310001825079us-gaap:MeasurementInputExpectedDividendRateMembervldx:July2024PrivateWarrantsMember2025-03-310001825079vldx:DebtForEquityExchangeMember2024-12-240001825079us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembervldx:A2023PrivatePlacementWarrantsBMember2024-12-310001825079vldx:WarrantLiabilityMembervldx:PrivatePlacementWarrantsMember2024-03-310001825079vldx:July2024PrivateWarrantsMembervldx:MeasurementInputExpectedVolatilityMember2025-03-310001825079vldx:EligibleVelo3DEquityholdersMember2025-01-012025-03-310001825079vldx:A2023PrivatePlacementWarrantsAMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079us-gaap:FairValueInputsLevel3Membervldx:BepoWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:A2024PrivateWarrantsLiabilityMember2024-12-310001825079vldx:AprilTwoThousandAndTwentyFourSecuritiesPurchaseAgreementMember2024-04-122024-04-120001825079vldx:BepoAgentWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:SeniorSecuredConvertiblePromissoryNoteMembervldx:JanuaryNoteMember2025-01-070001825079vldx:FebruaryNoteFirstTrancheMembervldx:SeniorSecuredConvertiblePromissoryNoteMember2025-01-012025-03-3100018250792024-06-100001825079us-gaap:FurnitureAndFixturesMember2025-03-310001825079us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembervldx:A2023PrivatePlacementWarrantsBMember2025-03-310001825079us-gaap:FairValueInputsLevel1Membervldx:July2024PrivateWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079srt:EuropeMember2024-01-012024-03-310001825079vldx:SeniorSecuredConvertiblePromissoryNoteMember2025-02-100001825079us-gaap:RestrictedStockUnitsRSUMember2024-03-310001825079vldx:CostOfSupportServicesMember2025-01-012025-03-310001825079us-gaap:RetainedEarningsMember2025-03-310001825079vldx:AugustInducementWarrantsMembervldx:MeasurementInputExpectedVolatilityMember2025-03-310001825079vldx:SeniorSecuredConvertiblePromissoryNoteMember2025-01-070001825079us-gaap:RetainedEarningsMember2024-03-310001825079us-gaap:MeasurementInputExpectedDividendRateMembervldx:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember2025-03-310001825079vldx:WarrantLiabilityMembervldx:A2023PrivateWarrantBMember2024-03-310001825079vldx:SeniorSecuredConvertiblePromissoryNoteMembervldx:FebruaryNoteMember2025-02-1000018250792025-03-310001825079us-gaap:FairValueInputsLevel3Membervldx:BepoAgentWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:ContingentEarnoutLiabilityMember2023-12-310001825079vldx:WarrantLiabilityMembervldx:July2024PrivateWarrantsMember2024-12-310001825079vldx:A2024PrivateWarrantsMembervldx:WarrantLiabilityMember2024-01-012024-03-310001825079us-gaap:MeasurementInputRiskFreeInterestRateMembervldx:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember2024-12-310001825079vldx:A2023PrivateWarrantAMembervldx:WarrantLiabilityMember2024-03-310001825079us-gaap:AdditionalPaidInCapitalMember2024-03-310001825079us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079vldx:A2024PrivateWarrantsMembervldx:WarrantLiabilityMember2023-12-310001825079vldx:JanuaryNoteMember2024-12-310001825079us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-310001825079us-gaap:MeasurementInputExpectedDividendRateMembervldx:AugustInducementWarrantsMember2025-03-310001825079vldx:ContingentEarnoutLiabilityMember2025-01-012025-03-310001825079vldx:BepoWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001825079vldx:A2022PrivatePlacementWarrantsAndA2023PrivateWarrantBMembervldx:MeasurementInputExpectedVolatilityMember2024-12-310001825079us-gaap:MeasurementInputRiskFreeInterestRateMembervldx:A2022PrivatePlacementWarrantsAndA2023PrivateWarrantBMember2025-03-310001825079vldx:BepoAgentWarrantsMembervldx:WarrantLiabilityMember2024-03-310001825079us-gaap:FairValueInputsLevel3Membervldx:BepoWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079vldx:CostOfSupportServicesMember2024-01-012024-03-310001825079vldx:BepoWarrantsAndBepoAgentWarrantLiabilitiesMembervldx:MeasurementInputExpectedVolatilityMember2024-12-310001825079vldx:Customer6Memberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310001825079vldx:A2022PrivatePlacementWarrantsMembervldx:WarrantLiabilityMember2024-01-012024-03-310001825079vldx:A2023PrivateWarrantAMembervldx:WarrantLiabilityMember2024-01-012024-03-310001825079vldx:WarrantToPurchaseCommonStockMember2025-03-310001825079vldx:Customer4Memberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-03-310001825079vldx:ComputersAndSoftwareMember2025-03-310001825079vldx:SecuredNotesMember2025-03-310001825079vldx:PlacementAgencyAgreementMember2024-04-100001825079vldx:WarrantToPurchaseCommonStockMember2025-03-310001825079vldx:A2024PrivateWarrantsMembervldx:WarrantLiabilityMember2024-12-310001825079us-gaap:AdditionalPaidInCapitalMember2023-12-310001825079vldx:A2023PrivateWarrantBMember2025-01-012025-03-310001825079vldx:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember2024-12-310001825079vldx:FebruaryTwoThousandAndTwentyFiveSecuritiesPurchaseAgreementMember2025-02-240001825079vldx:BepoAgentWarrantsMember2024-01-012024-12-310001825079vldx:BepoWarrantsMembervldx:WarrantLiabilityMember2023-12-310001825079us-gaap:MeasurementInputExpectedDividendRateMembervldx:A2022PrivatePlacementWarrantsAndA2023PrivateWarrantBMember2024-12-310001825079vldx:A2024PrivateWarrantsLiabilityMember2025-03-310001825079us-gaap:EmployeeStockOptionMember2024-01-012024-03-310001825079vldx:CommonStockWarrantsMember2025-03-310001825079vldx:ContingentEarnoutLiabilityMember2024-01-012024-03-310001825079us-gaap:RetainedEarningsMember2024-01-012024-03-310001825079vldx:A2024PrivateWarrantsLiabilityMemberus-gaap:MeasurementInputSharePriceMember2024-12-310001825079vldx:BepoAgentWarrantsMembervldx:WarrantLiabilityMember2023-12-310001825079vldx:A2023PrivateWarrantAMember2024-12-310001825079us-gaap:MeasurementInputExpectedDividendRateMember2025-03-310001825079vldx:July2024PrivateWarrantsMember2025-03-310001825079vldx:EligibleVelo3DEquityholdersMembersrt:MaximumMembervldx:JAWSSpitfireAcquisitionCorporationMember2021-09-292021-09-290001825079vldx:CommonStockWarrantsMembervldx:MeasurementInputExpectedVolatilityMember2025-03-310001825079vldx:A2022PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:A2022PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:BepoWarrantsMembervldx:WarrantLiabilityMember2025-01-012025-03-310001825079vldx:WarrantLiabilityMembervldx:A2023PrivateWarrantBMember2024-01-012024-03-310001825079us-gaap:MeasurementInputRiskFreeInterestRateMembervldx:July2024PrivateWarrantsMember2025-03-310001825079vldx:CostOf3DPrinterMember2025-01-012025-03-310001825079vldx:EarnoutShareUnitsMember2025-01-012025-03-310001825079vldx:BepoWarrantsMembervldx:WarrantLiabilityMember2024-01-012024-03-310001825079us-gaap:FairValueInputsLevel2Membervldx:A2023PrivatePlacementWarrantsAMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079us-gaap:ShareBasedCompensationAwardTrancheTwoMembervldx:SeniorSecuredConvertiblePromissoryNoteMember2025-02-100001825079vldx:AugustInducementWarrantsMember2024-12-310001825079srt:EuropeMember2025-01-012025-03-310001825079vldx:FebruaryNoteFirstTrancheMember2025-03-310001825079vldx:A2022PrivatePlacementWarrantsAndA2023PrivateWarrantBMembervldx:MeasurementInputExpectedVolatilityMember2025-03-3100018250792024-12-310001825079vldx:A2024PrivateWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-3100018250792024-01-012024-12-310001825079vldx:FebruaryNoteFirstTrancheMembervldx:SeniorSecuredConvertiblePromissoryNoteMember2025-02-100001825079us-gaap:MeasurementInputRiskFreeInterestRateMembervldx:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember2025-03-310001825079vldx:A2022PrivatePlacementWarrantsAndA2023PrivateWarrantBMemberus-gaap:MeasurementInputSharePriceMember2024-12-310001825079vldx:A2022PrivatePlacementWarrantsMember2025-03-310001825079us-gaap:LeaseholdImprovementsMember2025-03-310001825079vldx:CommonStockWarrantsMemberus-gaap:MeasurementInputSharePriceMember2025-03-310001825079vldx:PublicWarrantsMember2024-01-012024-12-310001825079vldx:EarnoutShareUnitsMember2024-01-012024-03-310001825079vldx:BepoWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079us-gaap:FairValueInputsLevel3Membervldx:AugustInducementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:WarrantLiabilityMembervldx:July2024PrivateWarrantsMember2024-01-012024-03-310001825079vldx:EligibleVelo3DEquityholdersMembervldx:JAWSSpitfireAcquisitionCorporationMember2021-09-292021-09-290001825079vldx:WarrantLiabilityMembervldx:A2023PrivateWarrantBMember2024-12-310001825079vldx:A2023PrivateWarrantAMembervldx:WarrantLiabilityMember2025-01-012025-03-310001825079vldx:DebtForEquityExchangeMembervldx:ArrayedNotesAcquisitionCorpMember2024-12-240001825079vldx:WarrantToPurchaseCommonStockMember2024-12-310001825079vldx:CommonStockWarrantsMemberus-gaap:MeasurementInputSharePriceMember2024-12-310001825079vldx:WarrantInducementAgreementMember2024-08-120001825079vldx:A2022PrivatePlacementWarrantsMember2024-12-310001825079vldx:RecurringPaymentMember2025-01-012025-03-310001825079us-gaap:CommonStockMember2025-03-310001825079vldx:AprilAndJulyTwoThousandTwentyFourUnregisteredWarrantsMembervldx:FebruaryTwoThousandAndTwentyFiveSecuritiesPurchaseAgreementMembervldx:HighTrailHoldersMember2025-02-240001825079us-gaap:RetainedEarningsMember2024-12-310001825079vldx:A2024PrivatePlacementWarrantsMember2024-01-012024-12-310001825079us-gaap:FairValueInputsLevel2Membervldx:AugustInducementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079us-gaap:FairValueInputsLevel3Membervldx:A2022PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:LaboratoryEquipmentMember2025-03-310001825079vldx:PrivateWarrantsMember2025-03-310001825079vldx:A2023PrivateWarrantAMembervldx:WarrantLiabilityMember2025-03-310001825079vldx:PrivateWarrantsMember2025-01-012025-03-310001825079vldx:MeasurementInputExpectedVolatilityMember2025-03-310001825079vldx:BepoWarrantsMember2024-12-310001825079us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembervldx:A2023PrivatePlacementWarrantsBMember2025-03-310001825079vldx:DebtForEquityExchangeMember2024-12-242024-12-240001825079vldx:BepoAgentWarrantsMembervldx:WarrantLiabilityMember2025-01-012025-03-310001825079us-gaap:FairValueMeasurementsRecurringMembervldx:A2023PrivatePlacementWarrantsBMember2024-12-310001825079vldx:Velo3DMember2025-01-012025-03-310001825079us-gaap:FairValueInputsLevel2Membervldx:A2022PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079vldx:BepoAgentWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079us-gaap:CommonStockMember2024-12-310001825079us-gaap:FurnitureAndFixturesMember2024-12-310001825079vldx:FebruaryNoteSecondTrancheMember2025-03-310001825079vldx:A2022PrivatePlacementWarrantsMembervldx:WarrantLiabilityMember2025-03-310001825079vldx:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember2025-03-310001825079vldx:WarrantLiabilityMembervldx:PrivatePlacementWarrantsMember2025-03-310001825079us-gaap:MeasurementInputExpectedDividendRateMembervldx:CommonStockWarrantsMember2024-12-310001825079vldx:July2024PrivateWarrantsMember2024-07-010001825079vldx:BepoWarrantsMembervldx:WarrantLiabilityMember2024-03-310001825079vldx:A2021EmployeeStockPurchasePlanMember2024-04-300001825079vldx:BepoAgentWarrantsMembervldx:WarrantLiabilityMember2025-03-310001825079vldx:WarrantLiabilityMembervldx:July2024PrivateWarrantsMember2024-03-310001825079us-gaap:MeasurementInputRiskFreeInterestRateMembervldx:AugustInducementWarrantsMember2025-03-310001825079us-gaap:RestrictedStockUnitsRSUMember2025-03-310001825079vldx:SeniorSecuredConvertiblePromissoryNoteMembervldx:FebruaryNoteSecondTrancheMember2025-01-012025-03-310001825079vldx:A2023PrivateWarrantBMember2024-01-012024-12-310001825079us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembervldx:A2023PrivatePlacementWarrantsBMember2025-03-310001825079us-gaap:AdditionalPaidInCapitalMember2024-12-310001825079vldx:AugustInducementWarrantsMember2025-03-310001825079us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001825079vldx:SecuredNotesMember2025-01-012025-03-310001825079us-gaap:MeasurementInputExpectedDividendRateMembervldx:A2024PrivateWarrantsLiabilityMember2025-03-310001825079vldx:SeniorSecuredConvertiblePromissoryNoteMemberus-gaap:SubsequentEventMember2025-04-070001825079vldx:CommonStockWarrantsMember2024-12-310001825079vldx:WarrantLiabilityMembervldx:PrivatePlacementWarrantsMember2024-12-310001825079us-gaap:MeasurementInputSharePriceMember2024-12-310001825079us-gaap:FairValueInputsLevel3Membervldx:A2023PrivatePlacementWarrantsAMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:BepoWarrantsMembervldx:WarrantLiabilityMember2024-12-310001825079vldx:SecuredNotesMember2024-12-310001825079vldx:AugustInducementWarrantsMember2024-01-012024-12-310001825079vldx:BepoWarrantsAndBepoAgentWarrantLiabilitiesMemberus-gaap:MeasurementInputSharePriceMember2024-12-310001825079vldx:WarrantLiabilityMembervldx:A2023PrivateWarrantBMember2025-03-310001825079vldx:A2021StockOptionPlanMemberus-gaap:StockCompensationPlanMember2025-03-310001825079vldx:BepoWarrantsMember2024-01-012024-12-310001825079vldx:WarrantToPurchaseCommonStockMember2025-01-012025-03-310001825079us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:A3DPrintersMember2024-01-012024-03-310001825079us-gaap:MeasurementInputExpectedDividendRateMembervldx:CommonStockWarrantsMember2025-03-310001825079us-gaap:MeasurementInputExpectedDividendRateMembervldx:July2024PrivateWarrantsMember2024-12-310001825079us-gaap:EmployeeStockOptionMember2025-01-012025-03-310001825079us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001825079vldx:OtherLocationsMember2025-01-012025-03-310001825079vldx:A2022PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-3100018250792025-05-090001825079us-gaap:CommonStockMember2024-03-310001825079vldx:July2024PrivateWarrantsMember2024-01-012024-12-310001825079vldx:July2024PrivateWarrantsMemberus-gaap:MeasurementInputSharePriceMember2025-03-310001825079vldx:BepoAgentWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079vldx:A2022PrivatePlacementWarrantsAndA2023PrivateWarrantBMemberus-gaap:MeasurementInputSharePriceMember2025-03-3100018250792024-03-310001825079us-gaap:RetainedEarningsMember2025-01-012025-03-310001825079vldx:AugustInducementWarrantsMembervldx:WarrantLiabilityMember2025-01-012025-03-310001825079vldx:PrivateWarrantsMember2024-01-012024-12-310001825079us-gaap:MeasurementInputExpectedDividendRateMembervldx:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember2024-12-310001825079vldx:ContingentEarnoutLiabilityMember2024-12-310001825079us-gaap:RestrictedStockUnitsRSUMember2024-12-310001825079us-gaap:MeasurementInputExpectedDividendRateMembervldx:AugustInducementWarrantsMember2024-12-310001825079us-gaap:MeasurementInputRiskFreeInterestRateMembervldx:A2024PrivateWarrantsLiabilityMember2024-12-310001825079vldx:A2022PrivatePlacementWarrantsMembervldx:WarrantLiabilityMember2025-01-012025-03-310001825079vldx:AugustInducementWarrantsMemberus-gaap:MeasurementInputSharePriceMember2025-03-310001825079vldx:PublicWarrantsMember2024-12-310001825079vldx:CostOf3DPrinterMember2024-01-012024-03-310001825079us-gaap:MeasurementInputRiskFreeInterestRateMembervldx:A2024PrivateWarrantsLiabilityMember2025-03-310001825079us-gaap:FairValueInputsLevel2Membervldx:A2024PrivateWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079srt:AmericasMember2024-01-012024-03-310001825079vldx:ContingentEarnoutLiabilityMember2025-03-310001825079vldx:Customer6Memberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-03-310001825079us-gaap:CommonStockMember2024-01-012024-03-310001825079vldx:A2023PrivateWarrantAMembervldx:WarrantLiabilityMember2023-12-310001825079us-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079us-gaap:ResearchAndDevelopmentExpenseMember2025-01-012025-03-310001825079vldx:A2022PrivatePlacementWarrantsMember2020-12-020001825079vldx:AugustInducementWarrantsMembervldx:WarrantLiabilityMember2025-03-310001825079us-gaap:SellingAndMarketingExpenseMember2024-01-012024-03-310001825079vldx:CommonStockWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-12-310001825079vldx:WarrantLiabilityMembervldx:PrivatePlacementWarrantsMember2024-01-012024-03-310001825079us-gaap:FairValueInputsLevel3Membervldx:BepoAgentWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079vldx:AprilTwoThousandTwentyFourRegisteredWarrantsMembervldx:HighbridgeHoldersAndAnsonHoldersMembervldx:FebruaryTwoThousandAndTwentyFiveSecuritiesPurchaseAgreementMember2025-02-240001825079vldx:July2024PrivateWarrantsMember2024-12-310001825079vldx:A2022PrivatePlacementWarrantsAndA2023PrivateWarrantBMember2025-03-310001825079vldx:MeasurementInputExpectedVolatilityMember2024-12-310001825079vldx:A2023PrivateWarrantAMember2025-03-310001825079us-gaap:LeaseholdImprovementsMember2024-12-310001825079vldx:BepoAgentWarrantsMember2024-12-310001825079vldx:AugustInducementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079us-gaap:FairValueInputsLevel3Membervldx:A2022PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079vldx:BepoWarrantsAndBepoAgentWarrantLiabilitiesMemberus-gaap:MeasurementInputSharePriceMember2025-03-310001825079us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001825079us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembervldx:Customer2Member2024-01-012024-03-310001825079vldx:HighbridgeHoldersAndAnsonHoldersMembervldx:AugustTwoThousandTwentyFourRegisteredWarrantsMembervldx:FebruaryTwoThousandAndTwentyFiveSecuritiesPurchaseAgreementMember2025-02-240001825079vldx:AugustInducementWarrantsMembervldx:MeasurementInputExpectedVolatilityMember2024-12-310001825079us-gaap:MeasurementInputRiskFreeInterestRateMember2024-12-310001825079us-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembervldx:A2023PrivatePlacementWarrantsBMember2024-12-310001825079vldx:Customer4Memberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310001825079us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembervldx:Customer3Member2024-01-012024-03-310001825079vldx:Customer5Memberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-03-310001825079vldx:AugustInducementWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079us-gaap:MeasurementInputExpectedDividendRateMembervldx:A2022PrivatePlacementWarrantsAndA2023PrivateWarrantBMember2025-03-310001825079vldx:WarrantLiabilityMembervldx:July2024PrivateWarrantsMember2023-12-310001825079vldx:A2021StockOptionPlanMember2025-03-310001825079vldx:NewWarrantsMember2024-08-120001825079us-gaap:FairValueInputsLevel2Membervldx:A2022PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:EligibleVelo3DEquityholdersMember2021-09-292021-09-290001825079vldx:AtTheMarketOfferingMember2025-03-310001825079vldx:A2023PrivateWarrantAMembervldx:WarrantLiabilityMember2024-12-310001825079vldx:OtherMember2024-01-012024-03-310001825079vldx:FebruaryNoteFirstTrancheMember2024-12-310001825079vldx:SeniorSecuredConvertiblePromissoryNoteMemberus-gaap:SubsequentEventMembervldx:JanuaryNoteMember2025-04-072025-04-070001825079vldx:BepoAgentWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:BepoAgentWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079vldx:BepoAgentWarrantsMember2025-01-012025-03-310001825079us-gaap:SellingAndMarketingExpenseMember2025-01-012025-03-310001825079vldx:AugustInducementWarrantsMembervldx:WarrantLiabilityMember2024-03-310001825079vldx:BepoWarrantsAndBepoAgentWarrantLiabilitiesMembervldx:MeasurementInputExpectedVolatilityMember2025-03-3100018250792025-01-012025-03-310001825079vldx:WarrantLiabilityMembervldx:July2024PrivateWarrantsMember2025-01-012025-03-310001825079vldx:Customer5Memberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310001825079us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembervldx:A2023PrivatePlacementWarrantsBMember2024-12-310001825079vldx:PrivateWarrantsMember2024-12-310001825079vldx:OtherMember2025-01-012025-03-310001825079us-gaap:MeasurementInputSharePriceMember2025-03-3100018250792023-12-310001825079us-gaap:StockCompensationPlanMembervldx:A2021StockOptionPlanMember2024-12-310001825079us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079vldx:A2023PrivateWarrantBMember2025-03-310001825079vldx:A2024PrivateWarrantsLiabilityMembervldx:MeasurementInputExpectedVolatilityMember2024-12-310001825079vldx:BepoAgentWarrantsMember2025-03-310001825079vldx:A2024PrivatePlacementWarrantsMember2025-03-310001825079vldx:A2022PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079vldx:SeniorSecuredConvertiblePromissoryNoteMembervldx:FebruaryNoteSecondTrancheMember2025-02-100001825079vldx:ATMSalesAgreementMember2023-02-012023-02-2800018250792024-01-012024-03-310001825079vldx:BepoWarrantsMember2025-01-012025-03-310001825079us-gaap:MeasurementInputRiskFreeInterestRateMembervldx:A2022PrivatePlacementWarrantsAndA2023PrivateWarrantBMember2024-12-310001825079vldx:WarrantLiabilityMembervldx:A2023PrivateWarrantBMember2025-01-012025-03-310001825079vldx:FebruaryTwoThousandAndTwentyFiveSecuritiesPurchaseAgreementMembervldx:HighTrailHoldersMembervldx:DecemberTwoThousandTwentyThreeRegisteredWarrantsMember2025-02-240001825079vldx:WarrantLiabilityMembervldx:July2024PrivateWarrantsMember2025-03-310001825079us-gaap:AdditionalPaidInCapitalMember2025-03-310001825079vldx:PublicWarrantsMember2025-01-012025-03-310001825079vldx:SeniorSecuredConvertiblePromissoryNoteMembervldx:JanuaryNoteMember2025-01-012025-03-310001825079vldx:AugustInducementWarrantsMemberus-gaap:MeasurementInputSharePriceMember2024-12-310001825079us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-310001825079vldx:A2022PrivatePlacementWarrantsMember2024-01-012024-12-310001825079vldx:A3DPrintersMember2025-01-012025-03-310001825079vldx:PublicWarrantsMember2025-03-310001825079vldx:SupportServicesMember2025-01-012025-03-310001825079vldx:JanuaryNoteMember2025-03-310001825079vldx:WarrantLiabilityMembervldx:PrivatePlacementWarrantsMember2025-01-012025-03-310001825079vldx:A2024PrivateWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:A2022PrivatePlacementWarrantsMember2025-01-012025-03-310001825079vldx:BepoWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:A2022PrivatePlacementWarrantsMembervldx:WarrantLiabilityMember2024-12-310001825079us-gaap:FairValueInputsLevel3Membervldx:A2024PrivateWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079us-gaap:EmployeeStockMember2024-12-310001825079us-gaap:GeneralAndAdministrativeExpenseMember2025-01-012025-03-310001825079vldx:Velo3DMemberus-gaap:SubsequentEventMembersrt:MaximumMember2025-04-120001825079vldx:A2022PrivatePlacementWarrantsMembervldx:WarrantLiabilityMember2023-12-310001825079vldx:A2024PrivateWarrantsMembervldx:WarrantLiabilityMember2024-03-310001825079us-gaap:GeneralAndAdministrativeExpenseMember2024-01-012024-03-310001825079vldx:AugustInducementWarrantsMembervldx:WarrantLiabilityMember2024-01-012024-03-310001825079us-gaap:RestrictedStockUnitsRSUMember2023-12-310001825079vldx:SeniorSecuredConvertiblePromissoryNoteMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2025-02-100001825079vldx:July2024PrivateWarrantsMembervldx:MeasurementInputExpectedVolatilityMember2024-12-310001825079vldx:A2023PrivateWarrantBMember2024-12-310001825079vldx:SeniorSecuredConvertiblePromissoryNoteMemberus-gaap:SubsequentEventMember2025-04-072025-04-070001825079vldx:EligibleVelo3DEquityholdersMember2024-01-012024-03-310001825079us-gaap:FairValueInputsLevel2Membervldx:July2024PrivateWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:WarrantToPurchaseCommonStockMember2024-01-012024-03-310001825079us-gaap:EmployeeStockOptionMember2025-01-012025-03-310001825079vldx:A2024PrivatePlacementWarrantsMember2024-12-310001825079vldx:A2024PrivateWarrantsMembervldx:WarrantLiabilityMember2025-01-012025-03-310001825079vldx:WarrantToPurchaseCommonStockMember2024-12-310001825079us-gaap:FairValueInputsLevel2Membervldx:BepoWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079us-gaap:FairValueInputsLevel2Membervldx:BepoWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-310001825079vldx:PrivatePlacementWarrantsMember2020-12-020001825079vldx:LaboratoryEquipmentMember2024-12-310001825079us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:RecurringPaymentMember2024-01-012024-03-310001825079us-gaap:FairValueInputsLevel3Membervldx:July2024PrivateWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:BepoAgentWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001825079vldx:SupportServicesMember2024-01-012024-03-310001825079vldx:BepoWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001825079vldx:AprilTwoThousandAndTwentyFourSecuritiesPurchaseAgreementMember2024-04-100001825079vldx:A2023PrivatePlacementWarrantsAMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:A2024PrivateWarrantsLiabilityMembervldx:MeasurementInputExpectedVolatilityMember2025-03-310001825079vldx:WarrantInducementAgreementMember2024-08-110001825079vldx:July2024PrivateWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001825079vldx:CommonStockWarrantsMembervldx:MeasurementInputExpectedVolatilityMember2024-12-310001825079us-gaap:EmployeeStockMember2025-03-310001825079vldx:AugustInducementWarrantsMembervldx:WarrantLiabilityMember2023-12-310001825079us-gaap:SalesRevenueNetMembervldx:Customer2Memberus-gaap:CustomerConcentrationRiskMember2025-01-012025-03-310001825079us-gaap:MeasurementInputExpectedDividendRateMembervldx:A2024PrivateWarrantsLiabilityMember2024-12-31iso4217:USDxbrli:sharesxbrli:purexbrli:sharesiso4217:USDvldx:Tranche

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________

FORM 10-Q

_____________________________

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2025

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____ to ____

Commission File Number: 001-39757

______________________________

Velo3D, Inc.

______________________________

(Exact name of registrant as specified in its charter)

Delaware

98-1556965

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

2710 Lakeview Court, Fremont, CA

94538

(Address of Principal Executive Offices)

(Zip Code)

(408) 610-3915

Registrant's telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

N/A

N/A

N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

 

 

 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No ☒

As of May 9, 2025, the registrant had 210,232,762 shares of common stock, $0.00001 per share outstanding.

 

 


 

TABLE OF CONTENTS

 

 

Page

Part I. Financial Information

 

 

 

Item 1.

Financial Statements (unaudited)

3

 

Condensed Consolidated Balance Sheets (unaudited)

3

 

Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)

4

 

Condensed Consolidated Statements of Cash Flows (unaudited)

5

 

Condensed Consolidated Statements of Stockholders’ Equity (unaudited)

7

 

Notes to Condensed Consolidated Interim Financial Statements (unaudited)

8

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

30

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

42

Item 4.

Controls and Procedures

42

 

 

 

Part II. Other Information

 

 

 

Item 1.

Legal Proceedings

44

Item 1A.

Risk Factors

44

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

47

Item 3.

Defaults Upon Senior Securities

47

Item 4.

Mine Safety Disclosures

47

Item 5.

Other Information

47

Item 6.

Exhibits

48

Signatures

49

 

 


 

Explanatory Note

Unless otherwise stated in this Quarterly Report or the context otherwise requires, references to:

Legacy Velo3D” refer to Velo3D, Inc., a Delaware corporation, prior to the closing of the Merger;
Merger” refer to the merger pursuant to that certain Business Combination Agreement, dated as of March 22, 2021, by and among JAWS Spitfire Acquisition Corporation, a Cayman Islands exempted company (“JAWS Spitfire”), Legacy Velo3D and Spitfire Merger Sub, Inc., a Delaware corporation (“Merger Sub”), as amended by Amendment No. 1 to the Business Combination Agreement, dated as of July 20, 2021 (the “Business Combination Agreement”), whereby Merger Sub merged with and into Legacy Velo3D, with Legacy Velo3D surviving the merger as a wholly-owned subsidiary of the Company, on September 29, 2021;
Velo3D” refer to Velo3D, Inc., a Delaware corporation (f/k/a JAWS Spitfire Acquisition Corporation, prior to its domestication), and its consolidated subsidiaries following the closing of the Merger;
we,” “us,” and “our” or the “Company” refer to Velo3D following the closing of the Merger and to Legacy Velo3D prior to the closing of the Merger; and
2024 Form 10-K” refer to our Annual Report on Form 10-K for the year-ended December 31, 2024, filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2025.

Velo”, “Velo3D”, “Sapphire” and “Intelligent Fusion” are registered trademarks of Velo3D, Inc; and “Without Compromise”, “Flow” and “Assure” are trademarks of Velo3D, Inc.

Cautionary Note Regarding Forward-looking Statements

Certain statements in this Quarterly Report may constitute “forward-looking statements” for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future, our strategic realignment and related initiatives, our market opportunities, and our future financial performance. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “can,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Quarterly Report involve significant risks and uncertainties, and a number of factors, both foreseen and unforeseen, could cause actual results to differ materially from our current expectations. The factors that may affect our results include, among others, the following:

our ability to generate positive cash flow and liquidity sufficient to meet our operating needs and satisfy our obligations;
our market opportunity;
our ability to execute our business plan, which may be affected by, among other things, competition and our ability to grow and manage growth profitably, raise financing in the near-term, fund our operating expenses, maintain relationships with customers and retain our key employees;
changes in applicable laws or regulations;
the inability to develop and maintain effective internal control over financial reporting;
our ability to service and comply with the terms of our indebtedness;
our ability to raise financing in the near-term and in the future;
our success in retaining or recruiting, or changes required in, our officers, key employees or directors;

1


 

whether our existing cash and cash equivalents will be sufficient to fund our operating expenses and capital expenditure requirements and our ability to continue as a going concern;
the potential for our business development efforts to maximize the potential value of our portfolio;
regulatory developments in the United States and foreign countries;
the impact of laws and regulations;
our ability to successfully implement our strategic realignment and related initiatives;
our capital requirements and needs for additional financing;
our financial performance;
macroeconomic conditions, including economic downturns or recessions, inflation, interest rate fluctuations and supply chain shortages; and
other factors detailed under the section entitled “Risk Factors” herein and in Item 1A of our 2024 Form 10-K.

The forward-looking statements contained in this Quarterly Report are based on current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described herein under the section entitled “Risk Factors” and in Item 1A of our 2024 Form 10-K. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Some of these risks and uncertainties may in the future be amplified by the impact of other macroeconomic factors and there may be additional risks that we currently consider immaterial or which are unknown. It is not possible to predict or identify all such risks. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

2


 

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

Velo3D, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share data)

 

 

March 31,

 

 

December 31,

 

 

2025

 

 

2024

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

3,870

 

 

$

1,212

 

Accounts receivable, net

 

 

4,569

 

 

 

3,723

 

Inventories, net

 

 

46,133

 

 

 

49,953

 

Contract assets

 

 

1,295

 

 

 

500

 

Prepaid expenses and other current assets

 

 

5,907

 

 

 

2,336

 

Total current assets

 

 

61,774

 

 

 

57,724

 

Property and equipment, net

 

 

13,691

 

 

 

14,270

 

Equipment on lease, net

 

 

3,673

 

 

 

3,673

 

Other assets

 

 

12,261

 

 

 

13,513

 

Total assets

 

$

91,399

 

 

$

89,180

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

16,365

 

 

$

18,538

 

Accrued expenses and other current liabilities

 

 

3,762

 

 

 

3,511

 

Debt – current portion

 

 

16,152

 

 

 

5,666

 

Contract liabilities

 

 

7,614

 

 

 

10,285

 

Total current liabilities

 

 

43,893

 

 

 

38,000

 

Long-term debt – less current portion

 

 

5,506

 

 

 

 

Contingent earnout liabilities

 

 

11

 

 

 

11

 

Warrant liabilities

 

 

13

 

 

 

2,167

 

Other noncurrent liabilities

 

 

9,094

 

 

 

9,338

 

Total liabilities

 

 

58,517

 

 

 

49,516

 

Commitments and contingencies (Note 13)

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

Common stock, $0.00001 par value - 500,000,000 shares authorized at March 31, 2025 and December 31, 2024, respectively, 210,232,762 and 194,909,430 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively

 

 

4

 

 

 

4

 

Additional paid-in capital

 

 

488,623

 

 

 

469,994

 

Accumulated other comprehensive loss

 

 

 

 

 

 

Accumulated deficit

 

 

(455,745

)

 

 

(430,334

)

Total stockholders’ equity

 

 

32,882

 

 

 

39,664

 

Total liabilities and stockholders’ equity

 

$

91,399

 

 

$

89,180

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

3


 

Velo3D, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

(In thousands, except share and per share data)

 

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

Revenue

 

 

 

 

 

 

3D Printer

 

$

7,523

 

 

$

7,660

 

Recurring payment

 

 

 

 

 

470

 

Support services

 

 

1,790

 

 

 

1,656

 

Other

 

 

7

 

 

 

 

Total Revenue

 

 

9,320

 

 

 

9,786

 

Cost of revenue

 

 

 

 

 

 

3D Printer

 

 

7,540

 

 

 

9,394

 

Recurring payment

 

 

12

 

 

 

315

 

Support services

 

 

1,071

 

 

 

2,892

 

Total cost of revenue

 

 

8,623

 

 

 

12,601

 

Gross profit (loss)

 

 

697

 

 

 

(2,815

)

Operating expenses

 

 

 

 

 

 

Research and development

 

 

1,212

 

 

 

5,043

 

Selling and marketing

 

 

2,275

 

 

 

4,809

 

General and administrative

 

 

9,131

 

 

 

8,783

 

Total operating expenses

 

 

12,618

 

 

 

18,635

 

Loss from operations

 

 

(11,921

)

 

 

(21,450

)

Interest expense

 

 

(1,070

)

 

 

(3,897

)

Gain (loss) on fair value of warrants

 

 

(1,044

)

 

 

(2,620

)

Gain (loss) on fair value of contingent earnout liabilities

 

 

 

 

 

(437

)

Gain (loss) on warrant cancellation

 

 

(11,357

)

 

 

 

Other income (expense), net

 

 

(11

)

 

 

94

 

Loss before provision for income taxes

 

 

(25,403

)

 

 

(28,310

)

Provision for income taxes

 

 

(8

)

 

 

(4

)

Net loss

 

$

(25,411

)

 

$

(28,314

)

 

 

 

 

 

 

Net loss per share:

 

 

 

 

 

 

    Basic

 

$

(0.13

)

 

$

(3.81

)

    Diluted

 

$

(0.13

)

 

$

(3.81

)

Shares used in computing net loss per share:

 

 

 

 

 

 

    Basic

 

 

200,971,566

 

 

 

7,436,976

 

    Diluted

 

 

200,971,566

 

 

 

7,436,976

 

 

 

 

 

 

 

Net loss

 

$

(25,411

)

 

$

(28,314

)

Net unrealized holding gain on available-for-sale investments

 

 

 

 

 

52

 

Total comprehensive loss

 

$

(25,411

)

 

$

(28,262

)

 

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

4


 

Velo3D, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

Cash flows from operating activities

 

 

 

 

 

 

Net loss

 

$

(25,411

)

 

$

(28,314

)

Adjustments to reconcile net loss to net cash used in operating activities

 

 

 

 

 

 

Depreciation and amortization

 

 

942

 

 

 

1,396

 

Amortization of debt discount and deferred financing costs

 

 

992

 

 

 

3,171

 

Stock-based compensation

 

 

4,074

 

 

 

5,087

 

Loss on fair value of warrants

 

 

1,044

 

 

 

2,620

 

Loss on fair value of contingent earnout liabilities

 

 

 

 

 

437

 

Loss on warrant cancellation

 

 

11,357

 

 

 

 

Changes in operating assets and liabilities

 

 

 

 

 

 

Accounts receivable

 

 

(846

)

 

 

(2,070

)

Inventories

 

 

1,989

 

 

 

2,645

 

Contract assets

 

 

(795

)

 

 

(2,118

)

Prepaid expenses and other current assets

 

 

(3,407

)

 

 

1,078

 

Other assets

 

 

1,224

 

 

 

396

 

Accounts payable

 

 

(860

)

 

 

(4,199

)

Accrued expenses and other liabilities

 

 

251

 

 

 

(218

)

Contract liabilities

 

 

(2,671

)

 

 

(416

)

Other noncurrent liabilities

 

 

(232

)

 

 

(18

)

Net cash used in operating activities

 

 

(12,349

)

 

 

(20,523

)

Cash flows from investing activities

 

 

 

 

 

 

Purchase of property and equipment

 

 

 

 

 

(6

)

Production of equipment for lease to customers

 

 

 

 

 

(1

)

Proceeds from maturity of available-for-sale investments

 

 

 

 

 

3,500

 

Net cash provided by investing activities

 

 

 

 

 

3,493

 

Cash flows from financing activities

 

 

 

 

 

 

Proceeds from secured convertible note

 

 

15,000

 

 

 

 

Issuance of common stock upon exercise of stock options

 

 

 

 

 

285

 

Net cash provided by financing activities

 

 

15,000

 

 

 

285

 

Effect of exchange rate changes on cash and cash equivalents

 

 

7

 

 

 

5

 

Net change in cash and cash equivalents

 

 

2,658

 

 

 

(16,740

)

Cash and cash equivalents and restricted cash at beginning of period

 

 

1,840

 

 

 

25,294

 

Cash and cash equivalents and restricted cash at end of period

 

$

4,498

 

 

$

8,554

 

 

 

 

 

 

 

 

Supplemental disclosure of cash flow information

 

 

 

 

 

 

Cash paid for interest

 

$

202

 

 

$

556

 

Supplemental schedule of non-cash investing and financing activities

 

 

 

 

 

 

Unpaid liabilities related to property and equipment

 

 

155

 

 

 

59

 

Transfer between inventory and property and equipment

 

 

191

 

 

 

 

Equipment for lease to customers returned to inventory

 

 

 

 

 

912

 

 

5


 

The following table provides a reconciliation of cash, cash equivalents, and restricted cash shown on the condensed consolidated statements of cash flows (unaudited):

 

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

 

 

(In thousands)

 

Cash and cash equivalents

 

$

3,870

 

 

$

7,754

 

Restricted cash (Other assets)

 

 

628

 

 

 

800

 

Total cash and cash equivalents and restricted cash

 

$

4,498

 

 

$

8,554

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

6


 

Velo3D, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited)

(In thousands, except share data)

 

 

 

Common Stock

 

 

Additional

 

 

Accumulated
Other

 

 

 

 

 

Total

 

 

Shares

 

 

Amount

 

 

Paid-In
Capital

 

 

Comprehensive
Loss

 

 

Accumulated
Deficit

 

 

Stockholders’
Equity

 

Balance as of December 31, 2023

 

 

7,502,478

 

 

$

2

 

 

$

425,471

 

 

$

(96

)

 

$

(357,037

)

 

$

68,340

 

Issuance of common stock upon exercise of stock
   options and release of restricted stock units

 

 

93,874

 

 

 

 

 

 

285

 

 

 

 

 

 

 

 

 

285

 

Stock-based compensation

 

 

 

 

 

 

 

 

5,087

 

 

 

 

 

 

 

 

 

5,087

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(28,314

)

 

 

(28,314

)

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

52

 

 

 

 

 

 

52

 

Balance as of March 31, 2024

 

 

7,596,352

 

 

$

2

 

 

$

430,843

 

 

$

(44

)

 

$

(385,351

)

 

$

45,450

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2024

 

 

194,909,430

 

 

$

4

 

 

$

469,994

 

 

$

 

 

$

(430,334

)

 

$

39,664

 

Issuance of common stock upon exercise of stock
   options and release of restricted stock units

 

 

470,953

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

 

 

 

4,074

 

 

 

 

 

 

 

 

 

4,074

 

Issuance of common stock in connection with warrant cancellation

 

 

14,852,379

 

 

 

 

 

 

14,555

 

 

 

 

 

 

 

 

 

14,555

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(25,411

)

 

 

(25,411

)

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of March 31, 2025

 

 

210,232,762

 

 

$

4

 

 

$

488,623

 

 

$

0

 

 

$

(455,745

)

 

$

32,882

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

7


 

Velo3D, Inc.

Notes to Condensed Consolidated Interim Financial Statements

(Unaudited)

Note 1. Description of Business and Basis of Presentation

Velo3D, Inc., a Delaware corporation (“Velo3D” ), formerly known as JAWS Spitfire Acquisition Corporation (“JAWS Spitfire”), produces metal additive three dimensional printers (“3D Printers”) which enable the production of components for space rockets, jet engines, fuel delivery systems and other high value metal parts, which it sells or leases to customers for use in their businesses. The Company also provides support services (“Support Services”) for an incremental fee.

Velo3D’s subsidiaries are Velo3D US, Inc., (formerly known as Velo3D, Inc. (“Legacy Velo3D”), founded in June 2014 as a Delaware corporation headquartered in Campbell, California), Velo3D, B.V., (a sales and marketing office located in the Netherlands) and Velo3D, GmbH, (a sales and marketing office located in Germany). The first commercially developed 3D Printer was delivered in the fourth quarter of 2018.

On September 29, 2021 (the “Closing Date” or the “Reverse Recapitalization Date”), JAWS Spitfire completed the previously announced merger with Legacy Velo3D, with Legacy Velo3D surviving as a wholly-owned subsidiary of JAWS Spitfire (the “Merger” or the “Reverse Recapitalization”). In connection with the Merger, JAWS Spitfire was renamed “Velo3D, Inc.”, and Legacy Velo3D was renamed “Velo3D US, Inc.”

The shares and net loss per share attributable to common stockholders, basic and diluted, prior to the Merger, have been retroactively restated as shares reflecting the exchange ratio (the “Exchange Ratio”) established in the Merger (0.8149 shares of Velo3D common stock for 1 share of Legacy Velo3D common stock, par value $0.00001 (the “common stock”) before the 1-to-35 reverse stock split). All fractional shares were rounded.

Unless otherwise stated herein or unless the context otherwise requires, references in these notes to the “Company” refer to (i) Legacy Velo3D prior to the consummation of the Merger; and (ii) Velo3D and its consolidated subsidiaries following the consummation of the Merger.

Basis of Presentation

The unaudited condensed consolidated interim financial statements include the accounts of the Company and its subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the requirements of the U.S. Securities and Exchange Commission (the “SEC”) for interim financial reporting. Intercompany balances and transactions have been eliminated in consolidation. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 (the “2024 Form 10-K”) and the related notes, which provide a more complete discussion of the Company’s accounting policies and certain other information. The condensed consolidated balance sheet as of December 31, 2024 has been derived from the audited consolidated financial statements of the Company. These unaudited condensed consolidated interim financial statements have been prepared on the same basis as the Company’s annual consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Company’s consolidated financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ended December 31, 2024, or for any other interim period or for any other future year.

On June 10, 2024, the stockholders of the Company approved an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the issued and outstanding shares of the Company’s common stock, par value $0.00001 per share, at a ratio ranging from 1-for-5 and 1-for-50, with the exact ratio to be set within that range by the Company’s board of directors (the “Board”). On June 10, 2024, the Board approved the reverse stock split at a ratio of 1-for-35 (the “Reverse Stock Split”). On June 12, 2024, the Company filed a Certificate of Amendment (the “Certificate of Amendment”) to the Company's Certificate of Incorporation with the Secretary of State of the State of Delaware to effect the Reverse Stock Split, effective as of June 13, 2024.

As a result of the Reverse Stock Split, every 35 shares of the Company's common stock were automatically reclassified and converted into one issued and outstanding share of common stock. No fractional shares were issued in connection with the Reverse Stock Split. Any fractional shares resulting from the Reverse Stock Split were rounded up to the nearest whole share. The par value of the Company’s common stock was not adjusted as a result of the Reverse Stock Split. All of the Company’s share numbers, per share amounts, and related stockholders’ equity (deficit) balances presented herein have been retroactively adjusted to reflect the Reverse

8


 

Stock Split. In addition, the exercise prices, conversion rates and other terms of the Company’s securities that adjusted pursuant to their terms as a result of the Reverse Stock Split have been presented after giving effect to such adjustments.

Delisting from the New York Stock Exchange ("NYSE") and Trading on OTC

On September 10, 2024 the Company received written notice from the New York Stock Exchange (the "NYSE") that the NYSE had determined to commence proceedings to delist the Company’s common stock and publicly traded warrants and that trading in such securities would be suspended immediately. On September 11, 2024, the Company commenced the trading of its common stock and warrants on the OTCQX Best Market.

Going Concern, Financial Condition and Liquidity and Capital Resources

The unaudited condensed consolidated interim financial statements have been prepared on the basis of continuity of operations, the realization of assets and satisfaction of liabilities in the ordinary course of business. The Company has incurred losses from operations and negative cash flows from operations in every year since inception and expects this to continue for the foreseeable future. As of March 31, 2025, the Company had an accumulated deficit of $455.7 million and cash and cash equivalents on hand of approximately $3.9 million.

Management believes that there is a substantial doubt concerning the Company’s ability to continue as a going concern. As of the date of the issuance of these unaudited condensed consolidated interim financial statements, the Company does not have sufficient liquidity to meet its operating needs and satisfy its obligations for at least 12 months from the date of issuance of the these unaudited condensed consolidated interim financial statements.

On December 9, 2024, Arrayed Notes Acquisition Corp. ("Arrayed"), a subsidiary of Arrayed Additive, Inc. purchased the Senior Secured Notes due 2026 from the the holders. Furthermore, on December 9, 2024, the Company and the the holders entered into a forbearance agreement where the Note Holders forbore from taking any enforcement action as a result of the occurrence and/or continuation of any specified events of default.

On December 24, 2024, the Company and Arrayed entered into a debt for equity exchange transaction where the Company issued 185,151,333 shares of the Company’s common stock, in exchange for the cancellation of $22.4 million in principal amount of the Company’s Secured Notes plus $0.4 million of accrued interest on the Notes. Arrayed continues to hold $5.0 million in principal amount of the Notes, and became the owner of approximately 95% of the Company’s issued and outstanding common stock.

In December 2023, the Board of Directors commenced a strategic business review process to explore alternatives in order to maximize stockholder value. The potential strategic alternatives actively being explored or evaluated currently included a potential merger, business combination or sale. The Company's strategic review was concluded on December 24, 2024, at the close of the debt for equity exchange transaction.

On January 7, 2025, the Company issued a Senior Secured Convertible Promissory Note in the principal amount of $5,000,000 (the "January Note") to Thieneman Properties, LLC, an Indiana limited liability company. The January Note bears interest at a rate of 60.0% per annum and was payable in full on April 7, 2025 in the amount of $5,750,000 and if not paid on or prior to such date, will continue to accrue interest at the same rate until paid. The January Note may be prepaid in whole or in part at any time without penalty or premium and is convertible in the event of default into shares of the Company’s common stock, at a fixed conversion price of $1.56 per share. On April 7, 2025, the Company paid an interest payment of $750,000, covering the first three months of interest on the January Note.

On February 10, 2025, the Company issued a Senior Secured Convertible Promissory Note in the principal amount of $10,000,000 (the "February Note") to Thieneman Construction, Inc, an Indiana corporation, to be funded in two tranches of $5,000,000. The February Note bears interest at a rate of 30.0% per annum, is payable in full on the date that is six months from the date such tranche was funded, in the amount of $5,750,000 and if not paid on or prior to such date, will continue to accrue interest at the same rate until paid. The outstanding principal amount of the February Note is convertible upon the occurrence of the Company’s successful listing of shares of its common stock on a national securities exchange or the occurrence and during the continuation of an event of default, into shares of the Company's common stock at a fixed conversion price of $1.00 per share.

Further, the Company will need to engage in additional financings to fund its operations and satisfy its obligations in the near-term. The Company is in discussions with multiple financing sources to attempt to secure additional financing. There are no assurances that the Company will be able to obtain financing on acceptable terms, or at all, to provide the necessary interim funding to continue its operations and satisfy its obligations for at least 12 months from the date of issuance of the unaudited condensed consolidated financial statements.

9


 

 

Note 2. Summary of Significant Accounting Policies

For a detailed discussion about the Company’s significant accounting policies and for further information on significant accounting updates adopted in the prior year, see Note 2, Summary of Significant Accounting Policies, to the audited consolidated financial statements in the 2024 Form 10-K. During the three months ended March 31, 2025, there were no significant updates to the Company’s significant accounting policies other than as described below.

Recently Issued Accounting Pronouncements

In December 2023, the Financial Accounting Standards Board (“FASB") issued Accounting Standards Update ("ASU") No. 2023-09 (“ASU 2023-09”), Income Taxes (Topic 740): Improvement to Income Tax Disclosures to enhance the transparency and decision usefulness of income tax disclosures. Two primary enhancements related to this ASU include disaggregating existing income tax disclosures relating to the effective tax rate reconciliation and income taxes paid. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact of this accounting standard update on the Company's condensed consolidated interim financial statements and related disclosures.

Licensing Revenue

Our revenue is partially derived from the licensing of computer software products and from their related maintenance contracts. We enter into contracts that include combinations of products, maintenance and services, which are accounted for as separate performance obligations with differing revenue recognition patterns.

Revenue from perpetual licenses is classified as software license revenue. Software license revenue is recognized up front upon delivery of the licensed product and/or the utility that enables the customer to access authorization keys, provided that an enforceable contract has been received. Typically, our perpetual licenses are sold with post-contract support (PCS), which includes unspecified technical enhancements and customer support. We allocate value in bundled perpetual and PCS arrangements based on the standalone selling prices of the perpetual license and PCS. Revenue from PCS is classified as maintenance revenue and is recognized either (i) ratably over the term of the contract or (ii) as the customer support is used at a specified hourly rate, as we satisfy the PCS performance obligation.

In addition to perpetual licenses, we sell time-based subscription licenses. Subscription licenses may be sold as a bundled arrangement that includes the rights to a term software license and PCS. Utilizing observable inputs, we determine a certain percentage of the estimated standalone selling price of the subscription lease license is attributable to the term license and the remainder is attributable to the PCS, based on factors pursuant to each arrangement. This determination considered the value relationship for our products between PCS and time-based subscription lease licenses, the value relationship between PCS and perpetual licenses, the average economic life of our products, software renewal rates and the price of the bundled arrangement in relation to the perpetual licensing approach. Consistent with the perpetual sales, the license component is classified as software license revenue and recognized as revenue up front upon delivery of the licensed product and/or utility that enables the customer to access authorization keys. The PCS is classified as maintenance revenue and is recognized ratably over the term of the contract, as we satisfy the PCS performance obligation.

Product Warranties

Our 3D printers are sold with a warranty period of typically one year from installation. After the warranty period, we generally offer service contracts that enable our customers to continue service and maintenance coverage. These service contracts are offered with various levels of support and options, and are priced accordingly. One entitlement of our service contracts is our service engineers provide periodic preventive maintenance visits to customer sites. Additionally, we provide training to our partners to enable them to also perform these services. Another contract entitlement on certain printer models is proactive remote troubleshooting capability through the Company’s integrated platform. From time to time, we also offer upgrade kits for certain of our printers that enable our existing customers to take advantage of new or enhanced printer capabilities. In some cases, we have discontinued upgrade support and maintenance agreements for certain of our older legacy printers.

Printers and certain other products include a warranty that covers workmanship, software, and hardware components under which we provide maintenance for periods up to one year. For these initial product warranties, estimated costs are accrued at the time of the sale of the product. These cost estimates are established using historical information regarding the nature, frequency and average cost

10


 

of claims for each type of printer or other product, as well as assumptions about future activity and events. Revisions to expense accruals are made as necessary based on changes in these historical and future factors.

Note 3. Basic and Diluted Net Loss per Share

The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders:

 

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

 

(In thousands, except share and per share data)

 

Numerator:

 

 

 

 

 

 

Net (loss)

 

$

(25,411

)

 

$

(28,314

)

Denominator:

 

 

 

 

 

 

Basic weighted average shares outstanding

 

 

200,971,566

 

 

 

7,436,976

 

Diluted weighted average shares outstanding

 

 

200,971,566

 

 

 

7,436,976

 

 

 

 

 

 

 

 

Net (loss) per share

 

 

 

 

 

 

Basic

 

$

(0.13

)

 

$

(3.81

)

Diluted

 

$

(0.13

)

 

$

(3.81

)

 

The following potentially dilutive shares of common stock equivalents “on an as-converted basis” were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect:

 

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

 

 

 

 

 

 

 

Common stock warrants

 

 

553,326

 

 

 

1,455,571

 

Common stock options

 

 

254,291

 

 

 

325,564

 

Restricted stock units

 

 

257,256

 

 

 

521,729

 

Total potentially dilutive common share equivalents

 

 

1,064,873

 

 

 

2,302,865

 

 

Total potentially dilutive common share equivalents for the three months ended March 31, 2025 and 2024 excludes 621,661 shares related to the earnout liability as these shares are contingently issuable upon meeting certain triggering events.

11


 

Note 4. Fair Value Measurements

The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:

 

 

Fair Value Measured as of March 31, 2025

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

(In thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds (i)

 

$

3,544

 

 

$

 

 

$

 

 

$

3,544

 

Total financial assets

 

$

3,544

 

 

$

 

 

$

 

 

$

3,544

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Common stock warrant liabilities (2022 Private Warrant) (iii)

 

 

 

 

 

 

 

 

 

 

 

 

Common stock warrant liabilities (Placement Agent
   Warrants) (iii)

 

 

 

 

 

 

 

$

3

 

 

 

3

 

Common stock warrant liabilities (BEPO
   Warrants) (iii)

 

 

 

 

 

 

 

 

6

 

 

 

6

 

Common stock warrant liabilities (BEPO Agent
   Warrants) (iii)

 

 

 

 

 

 

 

 

4

 

 

 

4

 

Contingent earnout liabilities

 

 

 

 

 

 

 

 

11

 

 

 

11

 

Total financial liabilities

 

$

 

 

$

 

 

$

24

 

 

$

24

 

 

 

Fair Value Measured as of December 31, 2024

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

(In thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds (i)

 

$

215

 

 

$

 

 

$

 

 

$

215

 

Total financial assets

 

$

215

 

 

$

 

 

$

 

 

$

215

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Common stock warrant liabilities (2022 Private Warrant) (iii)

 

$

 

 

$

 

 

$

1

 

 

$

1

 

Common stock warrant liabilities (RDO Warrants) (iii)

 

 

 

 

 

 

 

 

90

 

 

 

90

 

Common stock warrant liabilities (Placement Agent
   Warrants) (iii)

 

 

 

 

 

 

 

 

16

 

 

 

16

 

Common stock warrant liabilities (2024 Private
   Warrants) (iii)

 

 

 

 

 

 

 

 

378

 

 

 

378

 

Common stock warrant liabilities (BEPO
   Warrants) (iii)

 

 

 

 

 

 

 

 

18

 

 

 

18

 

Common stock warrant liabilities (BEPO Agent
   Warrants) (iii)

 

 

 

 

 

 

 

 

2

 

 

 

2

 

Common stock warrant liabilities (July 2024 Private Warrants) (iii)

 

 

 

 

 

 

 

 

865

 

 

 

865

 

Common stock warrant liabilities (August Inducement Warrants) (iii)

 

 

 

 

 

 

 

 

796

 

 

 

796

 

Contingent earnout liabilities

 

 

 

 

 

 

 

 

11

 

 

 

11

 

Total financial liabilities

 

$

 

 

$

 

 

$

2,177

 

 

$

2,177

 

 

(i)
Included in cash and cash equivalents on the unaudited condensed consolidated balance sheets.
(ii)
Included in short-term investments on the unaudited condensed consolidated balance sheets.
(iii)
Included in warrant liabilities on the unaudited condensed consolidated balance sheets.

For more information regarding the Public Warrants, the Private Placement Warrants, the 2022 Private Warrant, the RDO Warrants, the Placement Agent Warrants, the 2024 Private Warrants, the BEPO Warrants, and the BEPO Agent Warrants, July 2024 Private Warrants, August Inducement Warrants and the Contingent earnout liabilities, see Note 10, Equity Instruments.

The aggregate fair value of the Company’s money market funds approximated amortized cost and, as such, there were no unrealized gains or losses on money market funds as of March 31, 2025 and December 31, 2024. Realized gains and losses, net of tax, were not material for any of the periods presented.

12


 

The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments:

 

 

 

Private
placement
warrant
liabilities

 

 

2022
Private
Warrant

 

 

Contingent
earnout
liabilities

 

 

RDO
Warrants

 

 

Placement
Agent
Warrants

 

 

2024 Private Warrants

 

 

BEPO Warrants

 

 

BEPO Agent Warrants

 

 

July 2024 Private Warrants

 

 

August Inducement Warrants

 

 

(In thousands)

 

Fair value as of January 1, 2025

 

$

 

 

$

1

 

 

$

11

 

 

$

90

 

 

$

16

 

 

$

2

 

 

$

378

 

 

$

18

 

 

$

865

 

 

$

796

 

Change in fair value

 

 

 

 

(1

)

 

 

 

 

 

55

 

 

 

(13

)

 

 

(1

)

 

 

176

 

 

 

(14

)

 

 

441

 

 

 

402

 

Change due to exchange

 

 

 

 

 

 

 

 

 

 

 

(145

)

 

 

 

 

 

(1

)

 

 

(548

)

 

 

 

 

 

(1,306

)

 

 

(1,198

)

Fair value as of March 31, 2025

 

$

 

 

$

 

 

$

11

 

 

$

 

 

$

3

 

 

$

 

 

$

6

 

 

$

4

 

 

$

 

 

$

 

 

 

Private
placement
warrant
liabilities

 

 

2022
Private
Warrant

 

 

Contingent
earnout
liabilities

 

 

RDO
Warrants

 

 

Placement
Agent
Warrants

 

 

2024 Private Warrants

 

 

BEPO Warrants

 

 

BEPO Agent Warrants

 

 

July 2024 Private Warrants

 

 

August Inducement Warrants

 

 

(In thousands)

 

Fair value as of January 1, 2024

 

$

127

 

 

$

23

 

 

$

1,456

 

 

$

10,891

 

 

$

536

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

Change in fair value

 

 

114

 

 

 

5

 

 

 

437

 

 

 

2,162

 

 

 

108

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value as of March 31, 2024

 

$

241

 

 

$

28

 

 

$

1,893

 

 

$

13,053

 

 

$

644

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

The fair value of the private placement warrant liabilities, the 2022 Private Warrant, the contingent earnout liabilities, the RDO Warrants, the Placement Agent Warrants, the 2024 Private Warrants, the BEPO Warrants, the BEPO Agent Warrants, the July 2024 Private Warrants and the August Inducement Warrants are based on significant unobservable inputs, which represent Level 3 measurements within the fair value hierarchy.

In determining the fair value of the Private Placement Warrant liabilities, contingent earnout liabilities, and 2024 Private Warrants, the Company used the Monte Carlo simulation model using a distribution of potential outcomes on a weekly basis over the applicable periods that assumes optimal exercise of the Company’s redemption option at the earliest possible date (see Note 10, Equity Instruments).

In determining the fair value of the 2022 Private Warrant, RDO Warrants, Placement Agent Warrants, BEPO Warrants, BEPO Agent Warrants, July 2024 Private Warrants and August Inducement Warrants the Company used the Black-Scholes option pricing model to estimate the fair value using unobservable inputs including the expected term, expected volatility, risk-free interest rate and dividend yield (see Note 10, Equity Instruments).

Note 5. Investments

Available-for-sale Investments

There were no available-for-sale (“AFS”) investments as of March 31, 2025 and December 31, 2024.

 

There were no material realized gains or losses on AFS investments during the three months ended March 31, 2025 and March 31, 2024.

 

Note 6. Balance Sheet Components

Accounts Receivable, Net

Accounts receivable, net consisted of the following:

 

 

March 31,

 

 

December 31,

 

 

2025

 

 

2024

 

 

(In thousands)

 

Trade receivables

 

$

7,680

 

 

$

7,130

 

Less: Allowances for credit losses

 

 

(3,111

)

 

 

(3,407

)

Total

 

$

4,569

 

 

$

3,723

 

 

13


 

Inventories, Net

Inventories consisted of the following:

 

 

March 31,

 

 

December 31,

 

 

2025

 

 

2024

 

 

(In thousands)

 

Raw materials

 

$

30,189

 

 

$

29,386

 

Work-in-progress

 

 

4,032

 

 

 

9,660

 

Finished goods

 

 

11,912

 

 

 

10,907

 

Total

 

$

46,133

 

 

$

49,953

 

The Company recorded $27.1 million in inventory reserves related to the valuation of inventory as of March 31, 2025 and December 31, 2024.

 

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following:

 

 

March 31,

 

 

December 31,

 

 

2025

 

 

2024

 

 

(In thousands)

 

Prepaid insurance and other

 

$

1,909

 

 

$

1,724

 

Vendor prepayments

 

 

3,998

 

 

 

612

 

Total

 

$

5,907

 

 

$

2,336

 

 

Property and Equipment, Net

Property and equipment, net consisted of the following:

 

 

March 31,

 

 

December 31,

 

 

2025

 

 

2024

 

 

(In thousands)

 

Computers and software

 

$

2,525

 

 

$

2,525

 

Lab equipment and other equipment

 

 

11,357

 

 

 

11,011

 

Furniture and fixtures

 

 

206

 

 

 

206

 

Leasehold improvements

 

 

13,254

 

 

 

13,312

 

Total property, plant and equipment

 

 

27,342

 

 

 

27,054

 

Less accumulated depreciation and amortization

 

 

(13,651

)

 

 

(12,784

)

Property, plant and equipment, net

 

$

13,691

 

 

$

14,270

 

 

Depreciation expense for the three months ended March 31, 2025 and 2024 was $0.9 million and $1.1 million, respectively.

Other Assets

Other assets consisted of the following:

 

 

March 31,

 

 

December 31,

 

 

2025

 

 

2024

 

 

(In thousands)

 

Right of use assets

 

$

8,308

 

 

$

8,774

 

Net Investment in sales type lease

 

 

2,466

 

 

 

2,712

 

Non-current prepaid expenses and other assets

 

 

1,487

 

 

 

2,027

 

Total Other assets

 

$

12,261

 

 

$

13,513

 

 

14


 

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:

 

 

March 31,

 

 

December 31,

 

 

2025

 

 

2024

 

 

(In thousands)

 

Accrued expenses

 

$

1,647

 

 

$

1,173

 

Accrued salaries and benefits

 

 

379

 

 

 

560

 

Lease liability – current portion

 

 

1,736

 

 

 

1,778

 

Total Accrued expenses and other current liabilities

 

$

3,762

 

 

$

3,511

 

 

Other Noncurrent Liabilities

Other noncurrent liabilities consisted of the following:

 

 

March 31,

 

 

December 31,

 

 

2025

 

 

2024

 

 

(In thousands)

 

Lease liabilities – noncurrent portion

 

$

8,044

 

 

$

8,475

 

Other noncurrent liabilities

 

 

1,050

 

 

 

863

 

Total other noncurrent liabilities

 

$

9,094

 

 

$

9,338

 

 

Note 7. Equipment on Lease, Net

The equipment leased to customers had a cost basis of $4.6 million and accumulated depreciation of $0.9 million as of March 31, 2025. The equipment leased to customers had a cost basis of $4.6 million and accumulated depreciation of $0.9 million as of December 31, 2024.

The total depreciation expense was $0 and $0.3 million included in cost of revenue for the three months ended March 31, 2025 and 2024, respectively.

Lease payments from customers consisted of the following:

 

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

(In thousands)

 

Equipment on lease payments

 

$

 

 

$

470

 

The future lease payments expected in 2025 are $1.1 million.

 

 

Note 8. Leases

The Company leases its office and manufacturing facilities under four non-cancellable operating leases, including options to extend, which expire between 2025 to 2032. The agreements include a provision for renewal at the then prevailing market rate for terms specified in each lease.

Total right-of-use (“ROU”) assets and lease liabilities are as follows:

 

15


 

 

March 31,

 

 

December 31,

 

 

2025

 

 

2024

 

 

(In thousands)

 

Right-of-use assets:

 

 

 

 

 

 

Net book value (Other assets)

 

$

8,308

 

 

$

8,774

 

Operating lease liabilities:

 

 

 

 

 

 

Current (Accrued expense and other current liabilities)

 

$

1,590

 

 

$

1,612

 

Noncurrent (Other noncurrent liabilities)

 

 

7,968

 

 

 

8,361

 

 

 

9,558

 

 

 

9,973

 

Financing lease liabilities:

 

 

 

 

 

 

Current (Accrued expense and other current liabilities)

 

$

146

 

 

$

142

 

Noncurrent (Other noncurrent liabilities)

 

 

76

 

 

 

114

 

 

$

222

 

 

$

256

 

Total lease liabilities

 

$

9,780

 

 

$

10,229

 

 

There were no impairments recorded related to these assets as of March 31, 2025 and December 31, 2024.

Information about lease-related balances were as follows:

 

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

 

(In thousands, except years and percentages)

 

Operating lease expense

 

$

578

 

 

$

733

 

Financing lease expense

 

 

40

 

 

 

49

 

Short-term lease expense

 

 

41

 

 

 

68

 

Total lease expense

 

$

659

 

 

$

850

 

Cash paid for leases

 

$

595

 

 

$

746

 

Weighted – average remaining lease term – operating
   leases (years)

 

 

6.9

 

 

 

7.6

 

Weighted – average discount rate – operating leases

 

 

9.0

%

 

 

8.9

%

 

Maturity of operating lease liabilities as of March 31, 2025 are as follows:

 

Year Ending December 31,

 

(In thousands)

 

Remainder of 2025

 

$

1,794

 

2026

 

 

2,430

 

2027

 

 

2,400

 

2028

 

 

2,490

 

2029

 

 

2,585

 

Thereafter

 

 

6,195

 

Total operating lease payments

 

$

17,894

 

Less portion representing imputed interest

 

 

(8,336

)

Total operating lease liabilities

 

$

9,558

 

Less current portion

 

 

1,590

 

Long-term portion

 

$

7,968

 

 

16


 

Note 9. Debt

Debt consisted of the following:

 

 

March 31,

 

 

December 31,

 

 

2025

 

 

2024

 

 

(In thousands)

 

January Note

 

$

5,692

 

 

$

 

February Note 1st Tranche

 

 

5,204

 

 

 

 

February Note 2nd Tranche

 

 

5,046

 

 

 

 

Secured Notes

 

 

5,716

 

 

 

5,666

 

Total

 

$

21,658

 

 

$

5,666

 

Debt – current portion

 

 

16,152

 

 

 

5,666

 

Long-term debt – less current portion

 

$

5,506

 

 

$

 

 

As of March 31, 2025, the Company’s debt consists of the Secured Notes, the January Note, and the February Note. The Secured Notes entered into with Arrayed Notes Acquisition Corp. ("Arrayed"). The Company and Arrayed entered into a forbearance agreement where Arrayed forbore from taking any enforcement action as a result of the occurrences and/or continuation of any specified events of default. For a full description of the these debt arrangements, see Note 9, Debt, in the audited consolidated financial statements included in the 2024 Form 10-K.

Convertible Secured Note

On January 7, 2025, the Company issued the January Note, a Senior Secured Convertible Promissory Note in the principal amount of $5,000,000 to Thieneman Properties, LLC, an Indiana limited liability company. The January Note bears interest at a rate of 60.0% per annum, is payable in full on April 7, 2025 in the amount of $5,750,000 and if not paid on or prior to such date, will continue to accrue interest at the same rate until paid. The January Note may be prepaid in whole or in part at any time without penalty or premium and is convertible in the event of default into shares of the Company’s common stock, at a fixed conversion price of $1.56 per share. On April 7, 2025, the Company paid an interest payment of $750,000, which fulfilled it's obligations of interest owed through the aforementioned date. The Company continues to accrue interest on the principal amount of the January Note until such time it will be repaid. During the three months ended March 31, 2025, the Company incurred total interest expense of $0.7 million which is included in the carrying value of the January Note in the above table.

On February 10, 2025, the Company issued a Senior Secured Convertible Promissory Note (the “February Note”) in the principal amount of $10,000,000 to Thieneman Construction, Inc, an Indiana corporation, to be funded in two tranches of $5,000,000. This Note bears interest at a rate of 30.0% per annum, is payable in full on the date that is six months from the time the amounts are received by the Company. The first tranche (“February Note 1st tranche”) and second tranche (“February Note 2nd tranche”) were received by the Company on February 10, 2025 and March 20, 2025, respectively which become due on August 10, 2025 and September 20, 2025, respectively. If the February Notes is not paid on or prior to the aforementioned dates, the February Note will continue to accrue interest at the same rate until paid. The outstanding principal amount of the February Note is convertible at the option of the holder upon the occurrence of the Company’s successful listing of shares of its common stock on a national securities exchange or the occurrence and during the continuation of an Event of Default, into shares of the Company's common stock, at a fixed conversion price of $1.00 per share. During the three months ended March 31, 2025, the Company incurred total interest expense related to the February Note 1st tranche and February Note 2nd tranche of $0.2 million and less than $0.1 million, respectively, which is included in the carrying value in the above table.

Secured Notes

The Secured Notes bear interest at 6.00% per annum, payable quarterly in cash on January 1, April 1, July 1 and October 1 of each year, and will mature on August 1, 2026. When the Company repays principal on the Secured Notes pursuant to the terms of the Secured Notes, it will be required to pay 120% of the principal amount repaid (the “Repayment Price”) plus accrued and unpaid interest.

The Secured Notes include terms that provide the Arrayed seniority over other unsecured obligations in any settlement negotiations in the event of liquidation. Additionally, the Secured Notes contain redemption features in the event of default or a fundamental change in control that would make the Secured Notes immediately callable at a predetermined rate as described in the Secured Notes. The redemption features are settled in cash.

17


 

As of March 31, 2025, the unamortized discount was $0.3 million, which includes the difference between the principal and the Repayment Price. For the three months ended March 31, 2025, the Company incurred $0.1 million in interest expense, respectively, related to the Secured Notes. The effective interest rate was 8.7% for the three months ended March 31, 2025.

The future minimum aggregate payments for the above borrowings are equal to the quarterly payments made using the Repayment Price, are as follows as of March 31, 2025:

 

 

(In thousands)

 

Remainder of 2025

 

$

17,250

 

2026

 

 

5,993

 

Total

 

$

23,243

 

Less: Amount of debt discount to be amortized subsequent to March 31, 2025

 

 

(277

)

Less: Amount of interest to be accrued subsequent to March 31, 2025

 

 

(1,308

)

Debt as of March 31, 2025

 

$

21,658

 

 

Note 10. Equity Instruments

Common stock

Our authorized share capital consists of 500,000,000 shares of common stock, par value $0.00001 per share, and 10,000,000 shares of preferred stock, par value $0.00001 per share. As of March 31, 2025, we had 210,232,762 shares of common stock outstanding. The holders of common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders but are not entitled to cumulative voting rights, are entitled to receive ratably such dividends as may be declared by the Company’s Board of Directors out of funds legally available therefor subject to preferences that may be applicable to any shares of redeemable convertible preferred stock currently outstanding or issued in the future, are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preference of any then outstanding redeemable convertible preferred stock in the event of the Company’s liquidation, dissolution, or winding up, have no preemptive rights and no right to convert their common stock into any other securities, and have no redemption or sinking fund provisions applicable to the common stock.

April 2024 Securities Purchase Agreement

On April 10, 2024, the Company entered into securities purchase agreements (the “BEPO Purchase Agreements”) with certain investors (collectively, the “Purchasers”). The BEPO Purchase Agreements relate to the sale and issuance, on a reasonable best efforts basis (collectively, the “BEPO Offering”), by the Company of an aggregate of: (i) 979,592 shares of the Company’s common stock and (ii) warrants to purchase up to 979,592 shares of common stock (the “BEPO Warrants”). The offering price per share of common stock and the exercise price of the accompanying BEPO Warrants is $12.25.

On April 12, 2024, the Company completed the BEPO Offering, resulting in gross proceeds to the Company of approximately $12 million. The Company used the net proceeds from the BEPO Offering primarily for funding working capital and capital expenditures and other general corporate purposes, including repayment of a portion of the Company’s Secured Notes.

In connection with the BEPO Offering, on April 10, 2024, the Company also entered into a placement agency agreement (the “BEPO Placement Agency Agreement”) with A.G.P./Alliance Global Partners (the “BEPO Placement Agent”). Pursuant to the terms of the BEPO Placement Agency Agreement, the BEPO Placement Agent agreed to arrange for the sale of the shares of common stock and the warrants. The Company paid the BEPO Placement Agent a cash fee equal to 7.0% of the aggregate purchase price paid by the Purchasers in connection with sales and reimbursed the BEPO Placement Agent for certain of its expenses in an aggregate amount of $150,000. In addition, the Company issued Placement Agent warrants (the “BEPO Agent Warrants”) to purchase such number of shares of common stock equal to 5.0% of the aggregate number of shares of common stock sold in the BEPO Offering, or an aggregate of 48,980 shares of common stock. The BEPO Agent warrants are exercisable immediately upon issuance and have substantially the same terms as the BEPO Warrants, except that the BEPO Agent Warrants have an exercise price of $13.475 per share (representing 110% of the offering price per share of common stock and accompanying warrant) and will expire five years from the commencement of the sales pursuant to the BEPO Offering.

February 2025 Securities Purchase Agreement

 

On February 24, 2025, the Company entered into Warrant Exchange Agreements with each of: (i) Highbridge Tactical Credit Master Fund, L.P. (“HM”); (ii) Highbridge Tactical Credit Institutional Fund, Ltd. (collectively with HM, the “Highbridge Holders”); (iii) Anson Investments Master Fund LP (“AMF”); (iv) Anson East Master Fund LP (collectively with AMF, the “Anson Holders”);

18


 

(v) High Trail Investments ON LLC (“HTI”), and (vi) HB SPV I Master LLC (together with HTI, the “High Trail Holders”), pursuant to which: (a) the Highbridge Holders and the Anson Holders agreed to exchange an aggregate of 902,247 registered warrants issued in April 2024 and an aggregate of 1,485,714 registered warrants issued in August 2024, and (b) the High Trail Holders agreed to exchange an aggregate of 2,277,117 unregistered warrants issued in April 2024 and July 2024, and an aggregate of 285,715 registered warrants issued in December 2023, for an aggregate of 14,852,379 shares (the “Acquired Shares”) of Company’s common stock, respectively, equating in each case to an exchange ratio of three Acquired Shares for each warrant.

Common Stock Reserved for Future Issuance

Shares of common stock reserved for future issuance on an “as if converted” basis were as follows:

 

 

March 31,

 

 

December 31,

 

 

2025

 

 

2024

 

 

(share data)

 

Common stock warrants

 

 

553,326

 

 

 

5,504,117

 

Shares available for future grant under 2021 Equity Incentive Plan

 

 

43,957

 

 

 

696,840

 

Reserved for At-the-Market offering

 

 

80,742

 

 

 

80,742

 

Reserved for employee stock purchase plan

 

 

284,367

 

 

 

284,367

 

Total shares of common stock reserved

 

 

962,392

 

 

 

6,566,066

 

 

In February 2023, the Company entered into a sales agreement (the "ATM Sales Agreement") with Needham & Company, LLC ("Needham"), as agent, pursuant to which the Company may offer and sell, from time to time through Needham, up to $40.0 million shares of its common stock pursuant to a shelf registration statement on Form S-3 (the "Shelf Registration Statement") and the related prospectus supplement and accompanying base prospectus, and in connection therewith, the Company reserved 571,429 shares of common stock for issuance under the ATM Sales Agreement. On January 31, 2024, the Company filed an amendment to the prospectus supplement increasing the aggregate dollar amount of shares available to be sold from time to time pursuant to the ATM Sales Agreement to $75 million. During three months ended March 31, 2025, the Company sold no shares pursuant to the ATM sales agreement.

 

In April 2024, pursuant to the evergreen provisions of the Company’s 2021 Equity Incentive Plan (the “2021 EIP”), the Company added an additional 369,170 shares of common stock for issuance under the 2021 EIP and 73,748 shares of common stock for issuance under the 2021 ESPP.

The shares available for future grant under the 2021 EIP are net of any un-exercised stock options (vested and unvested) and unvested restricted stock units (“RSUs”) outstanding that may convert to common stock in the future upon exercise or vesting as of March 31, 2025 and December 31, 2024.

Common Stock Warrant Liabilities

In connection with the BEPO Offering, the Company issued BEPO Warrants to purchase up to an aggregate of 979,592 shares of common stock. The BEPO Warrants are immediately exercisable at an exercise price of $12.25 per share and will expire on the five year anniversary of the date of issuance. In connection with the BEPO Placement Agency Agreement, we also issued BEPO Agent Warrants to purchase up to 48,980 shares of common stock. The BEPO Agent Warrants are exercisable at an exercise price of $13.475 per share and will expire on the five year anniversary of the date of issuance.

In connection with the Second Note Amendment, on April 1, 2024, the Company also entered into a letter agreement (the “Letter Agreement”) with the Investors pursuant to which the Company issued to the Investors warrants (the “2024 Private Warrants”) to purchase up to an aggregate of 627,117 shares of Common Stock. The 2024 Private Warrants became exercisable 45 days after the original issuance date (the “Initial Exercise Date”), are exercisable at an exercise price of $13.29 per share and will expire on the one year anniversary of the later of (i) the Initial Exercise Date and (ii) the date on which the Resale Registration Statement (as defined in the Letter Agreement) is declared effective by the SEC. The Investors may exercise the 2024 Private Warrants by paying the exercise in cash or by reducing the outstanding principal amount under the Secured Notes by an amount equal to the quotient of (A) the amount of the exercise price divided by (B) 1.20. The 2024 Private Warrants may also be exercised on a cashless basis under certain circumstances.

In connection with the Third Note Amendment, on July 1, 2024, the Company also entered into a letter agreement with the Investors pursuant to which the Company issued to the Investors warrants (the “July 2024 Private Warrants”) to purchase up to an aggregate of 1,650,000 shares of Common Stock. The July 2024 Private Warrants became exercisable 45 days after the original issuance date, are exercisable at an exercise price of $2.50 per share and will expire on the five year anniversary of the issuance date.

19


 

The Investors may exercise the 2024 Private Warrants by paying the exercise in cash or by reducing the outstanding principal amount under the Secured Notes by an amount equal to the quotient of (A) the amount of the exercise price divided by (B) 1.20. The July 2024 Private Warrants may also be exercised on a cashless basis under certain circumstances.

On August 12, 2024, the Company entered into a warrant inducement with certain warrant holders. Pursuant to the Inducement Agreement, the holders of the Existing Warrants agreed to reduce the exercise price of their Existing Warrants totaling 742,857, from $19.78 per share to $2.28 per share. Additionally, the Company agreed to issue registered warrants with an exercise price of $2.28 per share to purchase 1,485,714 shares of Common Stock (the “August Inducement Warrants”) and will expire on the five year anniversary of the issuance date. The August Inducement Warrants may also be exercised on a cashless basis under certain circumstances.

Warrants to purchase an equal number of shares of common stock of 553,326 and 5,504,118 were exercisable as of March 31, 2025 and December 31, 2024, respectively. The Private Placement Warrants, the Public Warrants, the 2022 Private Warrant, the RDO Warrants, the Placement Agent Warrants, 2024 Private Warrants, BEPO Warrants, BEPO Agent Warrants, July 2024 Private Warrants and August Inducement Warrants to purchase shares of common stock are liability classified and recorded at fair value on the issue date with periodic remeasurement. Warrants for shares of common stock consisted of the following:

 

 

March 31, 2025

 

 

Issue Date

 

Expiration
Date

 

Number of
Warrants

 

 

Exercise
Price per
warrant

 

Private Placement Warrants - Common Stock

 

12/02/2020

 

09/29/2026

 

 

127,143

 

 

$

402.50

 

Public Warrants – Common Stock

 

12/02/2020

 

09/29/2026

 

 

246,429

 

 

$

402.50

 

2022 Private Warrant – Common Stock

 

07/25/2022

 

07/24/2034

 

 

2,000

 

 

$

89.60

 

Placement Agent Warrants - Common Stock

 

12/29/2023

 

12/29/2028

 

 

51,429

 

 

$

21.75

 

BEPO Warrants - Common Stock

 

4/12/2024

 

4/12/2029

 

 

77,345

 

 

$

12.25

 

BEPO Agent Warrants - Common Stock

 

4/12/2024

 

4/12/2029

 

 

48,980

 

 

$

13.48

 

 

 

 

 

 

 

553,326

 

 

 

 

 

 

December 31, 2024

 

 

Issue Date

 

Expiration
Date

 

Number of
Warrants

 

 

Exercise
Price per
warrant

 

Private placement warrants - Common Stock

 

12/02/2020

 

09/29/2026

 

 

127,143

 

 

$

402.50

 

Public warrants – Common Stock

 

12/02/2020

 

09/29/2026

 

 

246,429

 

 

$

402.50

 

2022 Private Warrant – Common Stock

 

07/25/2022

 

07/24/2034

 

 

2,000

 

 

$

89.60

 

RDO Warrants - Common Stock

 

12/29/2023

 

12/29/2028

 

 

285,714

 

 

$

19.95

 

2023 Placement Agent Warrants - Common Stock

 

12/29/2023

 

12/29/2028

 

 

51,429

 

 

$

21.75

 

2024 Private Warrants - Common Stock

 

4/1/2024

 

5/16/2025

 

 

627,117

 

 

$

13.29

 

BEPO Warrants - Common Stock

 

4/12/2024

 

4/12/2029

 

 

979,592

 

 

$

12.25

 

BEPO Agent Warrants - Common Stock

 

4/12/2024

 

4/12/2029

 

 

48,980

 

 

$

13.48

 

July 2024 Private Warrants - Common Stock

 

7/01/2024

 

7/01/2029

 

 

1,650,000

 

 

$

2.50

 

August Inducement Warrants - Common Stock

 

8/13/2024

 

08/12/2029

 

 

1,485,714

 

 

$

2.28

 

 

 

 

 

 

 

5,504,118

 

 

 

 

 

Warrant Liabilities Fair Value

The issuance of the Private Placement Warrant and Public Warrant liabilities were accounted for as a reverse recapitalization. The 2022 Private Warrant was issued in connection with the Company’s entry into the joinder and fourth loan modification with Silicon Valley Bank. See Note 9, Debt, in the consolidated financial statements included in the 2024 Form 10-K.

 

The liabilities associated with the Private Placement Warrants, 2022 Private Warrants, RDO Warrants, Placement Agent Warrants, 2024 Private Warrants, BEPO Warrants, BEPO Agent Warrants, July 2024 Private Warrants and August Inducement Warrants were subject to remeasurement at each balance sheet date using the Level 3 fair value inputs and the Public Warrants were subject to remeasurement at each balance sheet date using Level 1 fair value inputs for the three months ended March 31, 2025 and March 31, 2024. See Note 4, Fair Value Measurements, in this Report for liability classified warrants recorded at fair value.

20


 

Each Private Placement Warrant is exercisable to purchase one share of common stock at a price of $402.50 per share. Subject to certain exceptions, the Private Placement Warrants have terms and provisions that are identical to those of the Public Warrants. The 2022 Private Warrant is exercisable to purchase one share of common stock at a price of $89.60 per share and allows cashless exercise in whole or part. The Public Warrants may only be exercised for a whole number of shares. The Public Warrants became exercisable on December 7, 2021. The RDO Warrants are exercisable to purchase one share of common stock at a price of $19.95 per warrant share. The Placement Agent Warrants are exercisable to purchase one share of common stock at a price of $21.75 per warrant share . The RDO Warrants and 2023 Placement Agent Warrants are exercisable until December 29, 2028 and allows cashless exercise in whole or part.

Private Placement Warrants Fair Value Assumptions

The fair value of the private placement common stock warrant liability was $0 as of March 31, 2025 and December 31, 2024, as the publicly traded price was $0.00 as of March 31, 2025 and December 31, 2024. The assumptions used in the Monte Carlo simulation model for the recurring valuation of the private placement common stock warrant liability were as follows:

 

 

As of March 31, 2025

 

 

As of December 31, 2024

 

Current stock price

 

$

 

 

$

 

Expected volatility

 

 

%

 

 

%

Risk-free interest rate

 

 

%

 

 

%

Dividend rate

 

 

%

 

 

%

Expected Term (years)

 

 

 

 

 

 

 

Expected volatility: The volatility is determined iteratively, such that the concluded value of the Private Placement Warrants are equal to the traded price.

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the common stock warrants.

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.

Expected term: The expected term represents the period that the warrants are expected to be outstanding and is determined using the simplified method, which deems the term to be the average of the time to vesting and the contractual life of the common stock warrants.

2022 Private Warrants, RDO Warrants, 2023 Placement Agent Warrants - Fair Value Assumptions

The fair value assumptions used in the Black-Scholes simulation model for the recurring valuation of the 2022 Private Warrants, the RDO Warrants, and the 2023 Placement Agent Warrants liabilities were as follows:

 

 

As of March 31, 2025

 

 

As of December 31, 2024

 

Current stock price

 

$

0.17

 

 

$

0.68

 

Expected volatility

 

 

154.6

%

 

 

139.9

%

Risk-free interest rate

 

 

4.1

%

 

 

4.3

%

Dividend rate

 

 

%

 

 

%

Expected Term (years)

 

 

3.75

 

 

 

4.00

 

 

Expected volatility: The expected volatility was derived from the implied volatility of the Company’s publicly traded common stock.

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the common stock warrants.

21


 

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.

Expected term: The expected term represents the period that the warrant is expected to be outstanding and is determined using the simplified method, which deems the term to be the average of the time to vesting and the contractual life of the warrant.

2024 Private Warrants, - Fair Value Assumptions

The fair value assumptions used in the Monte Carlo simulation model for the valuation of the 2024 Private Warrants liability was as follows:

 

 

As of March 31, 2025

 

 

As of December 31, 2024

 

Current stock price

 

$

0.17

 

 

$

0.68

 

Expected volatility

 

 

222.9

%

 

 

191.6

%

Risk-free interest rate

 

 

4.3

%

 

 

4.2

%

Dividend yield

 

 

%

 

 

%

Expected Term (years)

 

 

0.13

 

 

0.37

 

 

Expected volatility: The expected volatility was derived from the implied volatility of the Company’s publicly traded common stock.

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the common stock warrants.

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.

Expected term: The expected term represents the period that the warrant is expected to be outstanding and is determined using the simplified method, which deems the term to be the average of the time to vesting and the contractual life of the warrant.

BEPO Warrants, BEPO Agent Warrant - Fair Value Assumptions

The fair value assumptions used in the Black-Scholes simulation model for the valuation of the BEPO Warrant and the BEPO Agent Warrant liabilities were as follows:

 

 

As of March 31, 2025

 

 

As of December 31, 2024

 

Current stock price

 

$

0.17

 

 

$

0.68

 

Expected volatility

 

 

154.6

%

 

 

139.9

%

Risk-free interest rate

 

 

4.1

%

 

 

4.4

%

Dividend yield

 

 

%

 

 

%

Expected Term (years)

 

 

4.04

 

 

4.28

 

 

Expected volatility: The expected volatility was derived from the implied volatility of the Company’s publicly traded common stock.

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the common stock warrants.

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.

22


 

Expected term: The expected term represents the period that the warrant is expected to be outstanding and is determined using the simplified method, which deems the term to be the average of the time to vesting and the contractual life of the warrant.

August Inducement Warrants - Fair Value Assumptions

The fair value assumptions used in the Black-Scholes simulation model for the valuation of the August Inducement Warrant liabilities were as follows:

 

As of March 31, 2025

 

 

As of December 31, 2024

 

Current stock price

 

$

0.17

 

 

$

0.68

 

Expected volatility

 

 

154.6

%

 

 

139.9

%

Risk-free interest rate

 

 

4.2

%

 

 

4.4

%

Dividend yield

 

 

%

 

 

%

Expected Term (years)

 

 

4.37

 

 

4.62

 

 

Expected volatility: The expected volatility was derived from the implied volatility of the Company’s publicly traded common stock.

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the common stock warrants.

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.

Expected term: The expected term represents the period that the warrant is expected to be outstanding and is determined using the simplified method, which deems the term to be the average of the time to vesting and the contractual life of the warrant.

July 2024 Private Warrants - Fair Value Assumptions

The fair value assumptions used in the Black-Scholes simulation model for the valuation of the July 2024 Private Warrant liabilities were as follows:

 

As of March 31, 2025

 

 

As of December 31, 2024

 

Current stock price

 

$

0.17

 

 

$

0.68

 

Expected volatility

 

 

154.6

%

 

 

139.9

%

Risk-free interest rate

 

 

3.9

%

 

 

4.4

%

Dividend yield

 

 

%

 

 

%

Expected Term (years)

 

 

4.25

 

 

 

4.50

 

 

Expected volatility: The expected volatility was derived from the implied volatility of the Company’s publicly traded common stock.

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the common stock warrants.

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.

Expected term: The expected term represents the period that the warrant is expected to be outstanding and is determined using the simplified method, which deems the term to be the average of the time to vesting and the contractual life of the warrant.

Contingent Earnout Liabilities

The contingent earnout liability is for Earnout Shares (as defined below) for pre-closing Legacy Velo3D equity holders (“Eligible Legacy Velo3D Equityholders”). During the time period between September 29, 2021 (the “Closing Date”) and the five-year

23


 

anniversary of the Closing Date, Eligible Legacy Velo3D Equityholders may receive up to 621,661 shares of common stock (the “Earnout Shares”), which is based on two tranches of 310,830 per tranche. The Earnout Shares issuable to holders of employee stock options are accounted as stock-based compensation expense as they are subject to forfeiture based on the satisfaction of certain employment conditions. See Note 11, Equity Incentive Plans & Stock Based Compensation, for further discussion.

See Note 4, Fair Value Measurements, in this Report for the liability for contingent earnout liabilities carried at fair value for the three months ended March 31, 2025 and 2024.

 

Fair Value Assumptions Contingent Earnout Liabilities

Assumptions used in the fair value of the contingent earnout liabilities are described below.

 

 

As of March 31, 2025

 

 

As of December 31, 2024

 

Current stock price

 

$

0.68

 

 

$

0.68

 

Expected volatility

 

 

161.2

%

 

 

161.2

%

Risk-free interest rate

 

 

4.2

%

 

 

4.2

%

Dividend yield

 

 

%

 

 

%

Expected Term (years)

 

 

1.50

 

 

1.75

 

 

Expected volatility: The expected volatility was derived from the implied volatility of the Company’s publicly traded common stock.

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the Earnout Shares.

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.

Expected term: The expected term represents the period that the Company’s stock-based awards are expected to be outstanding and is determined using the simplified method, which deems the term to be the average of the time to vesting and the contractual life of the Earnout Shares.

Note 11. Equity Incentive Plans and Stock-Based Compensation

As of March 31, 2025, the Company had a remaining allocated reserve of 43,957 shares of its common stock for issuance under its 2021 Equity Incentive Plan (the “2021 EIP”), which provides for the granting of stock options, restricted stock units (“RSUs”) and stock appreciation rights to employees, directors, and consultants of the Company. As of March 31, 2025, the Company had an allocated reserve of 284,367 shares of its common stock for issuance under its 2021 Employee Stock Purchase Plan (“2021 ESPP”). As of March 31, 2025, the Company had not begun any offering periods for the 2021 ESPP.

24


 

Stock options

Activity under the 2021 EIP is set forth below:

 

 

Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term
in years

 

 

(In thousands)

 

 

(Per share data)

 

 

(Years)

 

Outstanding as of December 31, 2023

 

 

376

 

 

$

21.35

 

 

 

6.2

 

Granted

 

 

 

 

$

 

 

 

 

Exercised

 

 

(46

)

 

$

6.30

 

 

 

 

Forfeited or expired

 

 

(4

)

 

$

28.35

 

 

 

 

Outstanding as of March 31, 2024

 

 

326

 

 

$

23.45

 

 

 

5.9

 

Options vested and expected to vest as of March 31, 2024

 

 

326

 

 

$

23.45

 

 

 

 

Vested and exercisable as of March 31, 2024

 

 

311

 

 

$

23.80

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2024

 

 

271

 

 

$

25.38

 

 

 

5.0

 

Granted

 

 

 

 

$

 

 

 

 

Exercised

 

 

 

 

$

 

 

 

 

Forfeited or expired

 

 

(53

)

 

$

13.17

 

 

 

 

Outstanding as of March 31, 2025

 

 

218

 

 

$

28.92

 

 

 

5.0

 

Options vested and expected to vest as of March 31, 2025

 

 

218

 

 

$

28.92

 

 

 

 

Vested and exercisable as of March 31, 2025

 

 

218

 

 

$

28.92

 

 

 

 

 

As of March 31, 2025 and December 31, 2024, there is no aggregate intrinsic value of options outstanding.

As of March 31, 2025, total unrecognized compensation cost related to options was immaterial and is expected to be recognized over a weighted-average period of less than a year.

For the three months ended March 31, 2025, there were no options granted.

Restricted Stock Units

The fair value of RSUs under the Company’s 2021 EIP is estimated using the value of the Company’s common stock on the date of grant.

25


 

The following table summarizes outstanding and expected to vest RSUs as of March 31, 2025 and 2024 and their activity during the three months ended March 31, 2025 and 2024:

 

 

Number
of Shares

 

 

Weighted-
Average
Grant Date
Fair Value

 

 

Aggregate
Intrinsic
Value

 

 

(In thousands)

 

 

(Per share data)

 

 

(In thousands)

 

Balance as of December 31, 2023

 

 

573

 

 

$

67.90

 

 

$

228

 

Granted

 

 

32

 

 

 

12.25

 

 

 

11

 

Released

 

 

(48

)

 

 

84.35

 

 

 

13

 

Cancelled

 

 

(36

)

 

 

67.20

 

 

 

14

 

Balance as of March 31, 2024

 

 

522

 

 

$

63.00

 

 

$

238

 

Expected to vest as of March 31, 2024

 

 

522

 

 

$

63.00

 

 

$

238

 

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2024

 

 

195

 

 

$

47.62

 

 

$

132

 

Granted

 

 

709

 

 

 

0.29

 

 

 

206

 

Released

 

 

(733

)

 

 

1.76

 

 

 

199

 

Cancelled

 

 

(18

)

 

 

51.40

 

 

 

20

 

Balance as of March 31, 2025

 

 

153

 

 

$

47.57

 

 

$

25

 

Expected to vest as of March 31, 2025

 

 

153

 

 

$

47.57

 

 

$

25

 

 

The aggregate intrinsic value of outstanding RSUs is calculated based on the closing price of the Company’s common stock as of the date outstanding. As of March 31, 2025, there was $6.6 million of unrecognized compensation cost, which is expected to be recognized over a weighted average period of approximately 2.2 years. As of March 31, 2024, there was $29.9 million of unrecognized compensation cost, which is expected to be recognized over a weighted average period of approximately 2.9 years.

Earnout Shares–Employees

The Earnout Shares issuable to holders of employee stock options are accounted as stock-based compensation expense as they are subject to forfeiture based on the satisfaction of certain employment conditions. The estimated fair values of the Earnout Shares associated with vested stock options are recognized as an expense and determined by the Monte Carlo simulation valuation model using a distribution of potential outcomes on a monthly basis over the five-year earnout period. The portion of the Earnout Shares associated with unvested stock options are recognized as an expense and considers the vesting continuing employment requirements.

Stock-based Compensation Expense

The following sets forth the total stock-based compensation expense by type of award included in operating expenses on the statements of operations:

 

 

Three Months Ended
March 31,

 

 

2025

 

 

2024

 

 

(In thousands)

 

Restricted stock units

 

$

3,591

 

 

$

3,829

 

Stock options

 

 

4

 

 

 

60

 

Earnout shares–employees

 

 

479

 

 

 

1,198

 

 

$

4,074

 

 

$

5,087

 

 

26


 

The following sets forth the total stock-based compensation expense for the stock options, RSUs, and earnout shares - employees included in cost of revenue and operating expenses on the statements of operations:

 

 

Three Months Ended
March 31,

 

 

2025

 

 

2024

 

 

(In thousands)

 

Cost of 3D Printer

 

$

140

 

 

$

389

 

Cost of Support services

 

 

68

 

 

 

195

 

Research and development

 

 

643

 

 

 

1,550

 

Selling and marketing

 

 

240

 

 

 

1,054

 

General and administrative

 

 

2,983

 

 

 

1,899

 

 

$

4,074

 

 

$

5,087

 

 

Note 12. Income Taxes

The income tax provision is calculated for an interim period by distinguishing between elements recognized in the income tax provision through applying an estimated annual effective tax rate (the “ETR”) to a measure of year-to-date operating results referred to as “ordinary income (or loss),” and discretely recognizing specific events referred to as “discrete items” as they occur. The income tax provision or benefit for each interim period is the difference between the year-to-date amount for the current period and the year-to-date amount for the period prior. Under ASC 740-270-30-36, entities subject to income taxes in multiple jurisdictions should apply one overall ERT instead of separate ETRs for each jurisdiction when calculating the interim-period income tax or benefit related to ordinary income (or loss) for the year-to-date interim period, except in certain circumstances. The Company’s effective tax rates for the three months ended March 31, 2025, and 2024 differ from the federal statutory rate of 21% principally as a result of valuation allowances expected to be applied to net operating loss carry-forwards which will not meet the threshold for recognition as deferred tax assets.

 

Note 13. Commitments and Contingencies

The Company may be involved in various lawsuits, claims, and proceedings, including intellectual property, commercial, securities, and employment matters that arise in the normal course of business. The Company accrues a liability when management believes information available prior to the issuance of the unaudited condensed consolidated interim financial statements indicates it is probable a loss has been incurred as of the date of the unaudited condensed consolidated interim financial statements and the amount of loss can be reasonably estimated. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Legal costs are expensed as incurred. As of March 31, 2025, the Company is not aware of any litigation, claim or assessment in which the outcome, individually or in the aggregate, would have a material adverse effect on its consolidated financial positions, results of operations, cash flows or future earnings.

The Company’s purchase obligations per terms and conditions with suppliers and vendors are cancellable in whole or in part prior to shipment. Non-cancellable purchase commitments (purchase orders) of $1.5 million for parts and assemblies are due upon receipt and are expected to be delivered throughout the remainder of 2025. If inventory is shipped, the Company will accrue a liability under accrued expenses. The Company has no other commitments and contingencies, except for the operating leases. See Note 8, Leases, for further discussion.

 

Note 14. Employee Defined-Contribution Plans

The Company has a defined-contribution plan intended to qualify under Section 401 of the Internal Revenue Code (the “401(k) Plan”). The Company contracted with a third-party provider to act as a custodian and trustee, and to process and maintain the records of participant data. Substantially all of the expenses incurred for administering the 401(k) Plan are paid by the Company. Accrued salaries and benefits included accruals related to the 401(k) plans the Company offers to its employees. In order to qualify for these plans, employees must meet the minimum age requirement (21 years) and begin participating on their entry date which is the first paycheck date in the month following the month of eligibility described above. Employee and employer contributions are immediately 100% fully vested. The plans offer employer contributions of 3.0% of an employee’s eligible compensation following safe-harbor rules. The Company’s contribution to the 401(k) Plan was $0.1 million and $0.3 million for the three months ended March 31, 2025 and 2024, respectively. The Company has paid all matching contributions as of March 31, 2025.

27


 

Note 15. Revenue

Customer Concentration

The customer concentration for balances greater than 10% of revenues and 10% of accounts receivables, net, respectively, are presented below:

 

 

Total Revenue

 

Accounts Receivable, Net

 

Three Months Ended March 31,

 

March 31,

 

December 31,

 

2025

 

2024

 

2025

 

2024

 

(as a percentage)

Customer 1

 

31.5%

 

—%

 

<10%

 

<10%

Customer 2

 

29.5%

 

26.8%

 

<10%

 

<10%

Customer 3

 

<10%

 

13.5%

 

<10%

 

<10%

Customer 4

 

—%

 

<10%

 

16.9%

 

18.2%

Customer 5

 

—%

 

—%

 

12.0%

 

12.9%

Customer 6

 

—%

 

—%

 

10.1%

 

10.8%

 

Revenue by Geographic Area

The Company currently sells its products in the geographic regions as follows:

 

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

 

(In thousands)

 

Americas

 

$

8,289

 

 

$

9,373

 

Europe

 

 

936

 

 

 

325

 

Other

 

 

95

 

 

 

88

 

Total

 

$

9,320

 

 

$

9,786

 

 

Contract Assets and Liabilities

There was $0.5 million of revenue recognized during the three months ended March 31, 2025, included in contract liabilities as of December 31, 2024. The amount of revenue recognized during the three months ended March 31, 2024 included in contract liabilities as of December 31, 2023 was $0.9 million. The change in contract assets reflects the difference in timing between the Company’s satisfaction of remaining performance obligations and the Company’s contractual right to bill its customers. The Company had no material asset impairment charges related to contract assets in the periods presented.

Variable Consideration

The Company estimates its variable consideration on a quarterly basis based on the latest data available, and adjusts the transaction price accordingly by recording an adjustment to net revenue and contract assets. The Company has recognized the estimate of variable consideration to the extent that it is probable that a significant reversal will not occur as a result of a change in estimation. There was no revenue related to variable consideration during the three ended March 31, 2025 and 2024.

28


 

Note 16. Subsequent Events

 

Master Service Agreement with Momentus

On April 12, 2025, the Company entered into a Master Service Agreement with Momentus, Inc. Under the terms of the agreement, for a period of five years, Velo3D will provide consulting and parts production through Velo3D's Rapid Production Solutions (RPS) offering. In exchange, Momentus issued a combination of common stock and convertible preferred stock for services that will be delivered over the same period. Velo3D will not hold more than 9.99% of the outstanding shares of Momentus' common stock at any time.

 

Change of Board of Directors

On April 24, 2025, the Company's Board of Directors appointed retired Navy Rear Admiral Jason Lloyd and Kenneth Thieneman, CEO of Thieneman Construction, Inc. to the Board as new directors. On April 22, 2025, Brad Kreger, Velo3D’s Chief Operating Officer, and Michael Idelchik resigned from the Board.

29


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis provides information which our management believes is relevant to an assessment and understanding of our results of operations and financial condition. This discussion should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2024 and our unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report. This discussion contains forward-looking statements based upon our current expectations, estimates and projections, and involves numerous risks and uncertainties. Actual results may differ materially from those contained in any forward-looking statements due to, among other considerations, the matters discussed in the sections titled “Risk Factors” and “Forward-looking Statements” herein. During the year ended December 31, 2024, we identified immaterial errors in our previously issued financial statements. We have corrected the amounts as presented in this Item 2 accordingly. Refer to Notes 1 and 16 to the unaudited condensed consolidated interim financial statements included in Part I of this Quarterly Report on Form 10-Q for additional information.

Overview

We seek to fulfill the promise of additive manufacturing, also referred to as 3D printing ("AM"), to deliver breakthroughs in performance, cost, and lead time in the production of high-value metal parts.

We produce a fully integrated hardware and software solution based on our proprietary laser powder bed fusion ("L-PBF") technology, which greatly reduces and often eliminates the need for support structures. Our technology enables the production of highly complex, mission-critical parts that existing AM solutions cannot produce without the need for redesign or additional assembly.

Our Sapphire Family of Printers give our customers who are in space, aviation, defense, automotive, energy and industrial markets the freedom to design and produce metal parts with complex internal features and geometries that had previously been considered impossible for AM. We believe our technology is years ahead of competitors.

Our technology is novel compared to other AM technologies because of its ability to deliver high-value metal parts that have complex internal channels, structures, and geometries. This affords a wide breadth of design freedom for creating new metal parts and it enables replication of existing parts without the need to redesign the part to be manufacturable with AM. Because of these features, we believe our technology and product capabilities are highly valued by our customers. Our customers are primarily original equipment manufacturers ("OEMs") and contract manufacturers ("CMs") who look to AM to solve issues with traditional metal parts manufacturing technologies. Those traditional manufacturing technologies rely on processes, including casting, stamping and forging, that typically require high volumes to drive competitive costs and have long lead times for production. Our customers look to AM solutions to produce assemblies that are lighter, stronger, and more reliable than those manufactured with traditional technologies. Our customers also expect AM solutions to drive lower costs for low-volume parts and substantially shorter lead times. However, many of our customers have found that other legacy AM technologies failed to produce the required designs for the high-value metal parts and assemblies that our customers wanted to produce with AM. As a result, other AM solutions often require that parts be redesigned so that they can be produced and frequently incur performance losses for high-value applications.

In contrast, our technology can deliver complex high value metal parts with the design advantages, lower costs and faster lead times associated with AM, and generally avoids the need to redesign the parts. As a result, our customers have increasingly adopted our technology into their design and production processes. We believe our value is reflected in our sales patterns, as most of our customers initially purchased a single machine to validate our technology and have purchased additional systems over time as they have embedded our technology in their product roadmap and manufacturing infrastructure. We consider this approach a “land and expand” strategy, oriented around a demonstration of our value proposition followed by increasing penetration with key customers.

Recent Developments
 

Recent Debt and Equity Transactions and Change in Majority Ownership

On December 24, 2024, the Company and Arrayed Note Acquisition Corp., a subsidiary of Arrayed Additive, Inc. (“Arrayed”), entered into a debt for equity exchange transaction where the Company issued 185,151,333 shares of the Company’s common stock, in exchange for the cancellation of $22.4 million in principal amount of the Company’s Secured Notes (the "Notes") plus $0.4 million of accrued interest on the Notes. As of March 31, 2025, Arrayed held $5.0 million in principal amount of the Notes, and as a result of the exchange transaction, became the owner of approximately 95% of the Company’s issued and outstanding common stock.

On February 24, 2025, the Company entered into Warrant Exchange Agreements with each of: (i) Highbridge Tactical Credit Master Fund, L.P. (“HM”); (ii) Highbridge Tactical Credit Institutional Fund, Ltd. (collectively with HM, the “Highbridge Holders”); (iii) Anson Investments Master Fund LP (“AMF”); (iv) Anson East Master Fund LP (collectively with AMF, the “Anson Holders”);

30


 

(v) High Trail Investments ON LLC (“HTI”), and (vi) HB SPV I Master LLC (together with HTI, the “High Trail Holders”), pursuant to which: (a) the Highbridge Holders and the Anson Holders agreed to exchange an aggregate of 902,247 registered warrants issued in April 2024 and an aggregate of 1,485,714 registered warrants issued in August 2024, and (b) the High Trail Holders agreed to exchange an aggregate of 2,277,117 unregistered warrants issued in April 2024 and July 2024, and an aggregate of 285,715 registered warrants issued in December 2023, for an aggregate of 14,852,379 shares (the “Acquired Shares”) of Company’s common stock, respectively, equating in each case to an exchange ratio of three Acquired Shares for each warrant.

On January 7, 2025, the Company issued a Senior Secured Convertible Promissory Note in the principal amount of $5,000,000 (the "January Note") to Thieneman Properties, LLC, an Indiana limited liability company. The January Note bears interest at a rate of 60.0% per annum, is payable in full on April 7, 2025 in the amount of $5,750,000 and if not paid on or prior to such date, will continue to accrue interest at the same rate until paid. The January Note may be prepaid in whole or in part at any time without penalty or premium and is convertible in the event of default into shares of the Company’s common stock, at a fixed conversion price of $1.56 per share.On April 7, 2025, the Company paid an interest payment of $750,000, covering the first three months of interest on the January Note.

On February 10, 2025, the Company issued a Senior Secured Convertible Promissory Note in the principal amount of $10,000,000 (the "February Note") to Thieneman Construction, Inc, an Indiana corporation, to be funded in two tranches of $5,000,000. The February Note bears interest at a rate of 30.0% per annum, is payable in full on the date that is six months from the date such tranche was funded, in the amount of $5,750,000 and if not paid on or prior to such date, will continue to accrue interest at the same rate until paid. The outstanding principal amount of the February Note is convertible into shares of the Company's common stock upon the occurrence of the Company’s successful listing of shares of its common stock on a national securities exchange or the occurrence and during the continuation of an event of default, into common stock at a fixed conversion price of $1.00 per share.

See Note 16 Subsequent Events in the notes to our unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report for additional information.

Notwithstanding the recent debt and equity transactions, as described in “—Liquidity and Capital Resources” and in Note 1 Description of Business and Basis of Presentation—Going Concern, Financial Condition and Liquidity and Capital Resources in the notes to the unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report, there continues to be a substantial doubt about our ability to continue as a going concern. We do not have sufficient liquidity to meet our operating needs and satisfy our debt obligations for at least the next 12 months. The Company will need to engage in additional financings to fund our operations, continue to fund payroll for employees, and satisfy our obligations in the near term. Without such additional funding, we will not be able to continue operations and may be required to sell assets, liquidate and/or file for bankruptcy.

Key Financial and Operational Metrics

We believe that our performance and future success depend on many factors that present significant opportunities for us but also pose risks and challenges, including those discussed herein and in the section of the 2024 Form 10-K titled “Risk Factors.”

We regularly evaluate several metrics, including the metrics presented in the table below, to measure our performance, identify trends affecting our business, prepare financial projections, make strategic decisions, and establish performance goals for compensation and we periodically review and revise these metrics to reflect changes in our business.

 

 

As of and for the Three Months Ended March 31,

 

 

2025

 

 

2024

 

Revenue ($ in millions)

 

$

9

 

 

$

10

 

Bookings ($ in millions)

 

$

8

 

 

$

17

 

Backlog ($ in millions)

 

$

18

 

 

$

22

 

 

Bookings ($ in millions): Bookings ($ in millions) are defined as a confirmed order for a 3D printer system and printed parts in contracted dollars.

Backlog ($ in millions): Backlog ($ in millions) is defined as the unfulfilled 3D printer systems and printed parts to be delivered to customers in contracted dollars as of period end.

31


 

Customer Concentration

Our operating results for the foreseeable future will continue to depend on sales to a small group of customers. For the three months ended March 31, 2025 and 2024, sales to the top three customers accounted for 70.7% and 49.9%, respectively, of our revenue. Of the top three customers for the three months ended March 31, 2025, two customers were different from the top three customers for the comparable period in 2024.

While our objective is to diversify our customer base, we continue to be susceptible to risks associated with customer concentration.

Continued Investment and Innovation

We continue to be a customer-focused company working to develop innovative solutions to address customers’ needs and focus on our customers to identify the most impactful areas for research and development as we seek to further improve the capabilities of our AM solutions. We believe this process has contributed significantly to our development of the most advanced metal AM systems in the world. We believe that continued investments in our products are important to our future growth and, as a result, we will invest in enhancing our portfolio of AM solutions through certain research and development projects based on customer demand.

Macroeconomic Conditions and Other World Events

General economic and political conditions such as recessions, interest rates, fuel prices, inflation, foreign currency fluctuations, international tariffs, social, political and economic risks and acts of war or terrorism (including, for example, the ongoing military conflicts in Israel and in Ukraine and the economic sanctions related thereto), have added uncertainty in timing of customer orders and supply chain constraints. In 2024, we implemented a number of supply chain and manufacturing improvements in response and intend to continue to focus on driving further operational improvements during 2025 to reduce operating costs.

See “Risk Factors - Risks Related to Our Business and Industry—Market conditions, economic uncertainty or downturns could adversely affect our business and operating results” and “—We may be adversely affected by the effects of inflation or possible stagflation.”

Climate Change

Material pending or existing climate change-related legislation, regulations, and international accords could have an adverse effect on our business, financial condition, and results of operations, including: (1) material past and/or future capital expenditures for climate-related projects, (2) material indirect consequences of climate-related regulation or business trends, such as the following: decreased/increased demand for goods or services that produce significant greenhouse gas emissions or are related to carbon-based energy sources; increased competition to develop innovative new products that result in lower emissions; increased demand for generation and transmission of energy from alternative energy sources; and any anticipated reputational risks resulting from operations or products that produce material greenhouse gas emissions and (3) material increased compliance costs related to climate change. In addition, extreme weather and other natural disasters may become more intense or more frequent, which may disrupt our operations or the operations of our suppliers and customers.

Components of Results of Operations

Revenue

Our revenue is primarily derived from our AM fully integrated hardware and software solution based on our proprietary L-PBF technology. Our products include Sapphire, Sapphire 1MZ, Sapphire XC and Sapphire XC 1MZ metal AM printer using our L-PBF technology and Assure quality validation software (collectively referred to as the “3D Printer”). Contracts for 3D Printers also include post-sale customer support services (“Support Services”), except for our distributor partners, which are qualified to perform support services.

We sell our fully integrated hardware and software AM solutions through two types of transaction models: a 3D Printer sale transaction and a recurring payment transaction (“Recurring Payment”). Support services are included with a 3D Printer sale transaction and a Recurring Payment transaction. For 3D Printer sale transactions where the support service period has expired, customers may purchase extended support service contracts.

32


 

3D Printer sale transactions - fixed purchase price model. The timeframe from order to completion of the site acceptance test usually occurs over three to nine months. As we scale our production, we expect to reduce this timeframe. Contract consideration allocated to the 3D Printer is recognized at a point in time, which occurs upon transfer of control to the customer at shipment.

The initial sales of 3D Printers and Support Services are included in one contract and are invoiced together. Contract consideration is allocated between the two performance obligations based on relative fair value. This allocation involves judgment and is periodically updated as new relevant information becomes available.

Other revenue included under 3D Printer sales includes parts and consumables, such as filters, powder or build plates, that are sold to customers and recognized upon transfer of control to the customer at shipment.

Recurring Payment transactions - are our leased 3D Printer transactions. We define our Recurring Payment transactions as operating leases. Under the leased 3D Printer transaction, the customer typically pays an amount for a lease which entitles the customer to a base number of hours of usage. For usage above that level, the customer typically pays an hourly usage fee. Most of our leases have a 12-month term, though in some instances the lease term is longer.

Under this model, the customer typically pays a base rent and variable payments based on usage in excess of a defined threshold. Most of our leases have a 12-month term, though in certain cases the lease term is longer.

Rapid Production Solutions (RPS) - RPS utilizes our deep engineering expertise, cutting-edge technology and a fleet of Sapphire XC large-format metal 3D printers to manufacture custom metal components in order to accelerate path to production for our customers.

Support Services - are included with most 3D Printer sale transactions and Recurring Payment transactions. Support services consist of field service engineering, phone and email support, preventative maintenance, and limited on and off-site consulting support. A subsequent Extended Support Agreement is available for renewal after the initial contract period based on the then-fair value of the service, which is paid for separately. Support Service revenue is recognized over the contract period beginning with customer performance test acceptance.

Cost of Revenue

Our cost of revenue includes the “Cost of 3D Printers,” “Cost of Recurring Payment” and “Cost of Support Services.”

Cost of 3D Printers includes the manufacturing cost of our components and subassemblies purchased from vendors for the assembly, as well as raw materials and assemblies, shipping costs and other directly associated costs. Cost of 3D Printers also includes allocated overhead costs from headcount-related costs, such as salaries, stock-based compensation, depreciation of manufacturing related equipment and facilities, and information technology costs.

Cost of Recurring Payment includes depreciation of the leased equipment over the useful life of five years less the residual value, and an allocated portion of Cost of Support Services.

Cost of RPS includes cost of raw materials, typically metal powder feedstock, direct and indirect labor, depreciation of 3D printers and other related equipment and facilities, utilities such as electricity and specialty gases, shipping costs and other directly associated costs.

Cost of Support Services includes the cost of spare or replacement parts for preventive maintenance, installation costs, headcount-related costs such as salaries, stock-based compensation, depreciation of manufacturing related equipment and facilities, and information technology costs. The headcount-related costs are directly associated with the engineers dedicated to remote and on-site support, training, travel costs and other services costs.

Gross Profit and Gross Margin

Our gross profit is revenue less cost of revenue and our gross margin is gross profit as a percentage of revenue. The gross profit and gross margin for our products are varied and are expected to continue to vary from period to period due to the mix of products and services sold through a 3D Printer sale transaction, a Recurring Payment transaction, RPS offerings, services contracts, new product introductions and efforts to optimize our operational costs. Other factors affecting our gross profit include changes to our material costs, assembly costs that are themselves dependent upon improvements to yield, and any increase in assembly overhead to support a greater number of 3D Printers sold and markets served.

33


 

Research and Development Expenses

Our research and development expenses represent costs incurred to support activities that advance the development of innovative AM technologies, new product platforms and consumables, as well as activities that enhance the capabilities of our existing product platforms. Our research and development expenses consist primarily of salaries and related personnel costs for individuals working in our research and development departments, including stock-based compensation, prototypes, design expenses, information technology costs and software license amortization, consulting and contractor costs, and an allocated portion of overhead costs, including depreciation of property and equipment used in research and development activities.

Selling and Marketing Expenses

Sales and marketing expenses consist primarily of salaries and related personnel costs for individuals working in our sales and marketing departments, including stock-based compensation, costs related to trade shows and events, advertising, marketing promotions, travel costs and an allocated portion of overhead costs, including information technology costs and costs for customer validation.

General and Administrative Expenses

General and administrative expenses consist primarily of salaries and related personnel costs for individuals associated with our executive, administrative, finance, legal, information technology and human resources functions, including stock-based compensation, professional fees for legal, audit and compliance, accounting and consulting services, general corporate costs, facilities, rent, information technology costs, insurance, bad debt expenses and an allocated portion of overhead costs, including equipment and depreciation and other general and administrative expenses.

Interest Expense

Interest expense primarily consists of interest incurred under our outstanding debt and finance leases.

Gain (Loss) on Fair Value of Warrants

Gain (loss) on valuation of warrant liabilities relates to the changes in the fair value of warrant liabilities which are subject to remeasurement at each balance sheet date.

Gain (Loss) on Fair value of Contingent Earnout Liabilities

Gain (loss) on valuation of contingent earnout liabilities relates to the changes in fair value of the contingent earnout liabilities in connection with the earnout shares, which are subject to remeasurement at each balance sheet date.

Loss on warrant cancellation

Loss on warrant cancellation relates to the loss recognized in conjunction with the February 2025 Warrant Exchange Agreement.

Other Income (Expense), Net

Other income (expense), net includes interest earned on our bank sweep account, gains and losses on disposals of fixed assets, transaction costs related to the warrant inducement transaction and other miscellaneous income/expenses.

Income Taxes

No provision for federal and state income taxes was recorded for any periods presented due to projected losses, and we maintained a full valuation allowance on the deferred tax assets as of March 31, 2025 and 2024.

We will continue to review our conclusions about the appropriate amount of the valuation allowance on a quarterly basis. If we were to generate profits, the U.S. valuation allowance position could be reversed in the foreseeable future. We expect a benefit to be recorded in the period the valuation allowance reversal is recorded and a higher effective tax rate in periods following the valuation allowance reversal.

34


 

Results of Operations

Comparison of the Three Months Ended March 31, 2025 and 2024:

The following table summarizes our historical results of operations for the periods presented:

 

 

Three Months Ended March 31,

 

 

 

 

 

2025

 

2024

 

Change

 

%

 

(In thousands, except for percentages)

Revenue

 

 

 

 

 

 

 

 

3D Printer

 

$7,523

 

$7,660

 

$(137)

 

(1.8)%

Recurring payment

 

 

470

 

(470)

 

(100.0)%

Support services

 

1,790

 

1,656

 

134

 

8.1%

Other

 

7

 

 

7

 

100.0%

Total Revenue

 

9,320

 

9,786

 

(466)

 

(4.8)%

Cost of revenue

 

 

 

 

 

 

 

 

3D Printer

 

7,540

 

9,394

 

(1,854)

 

(19.7)%

Recurring payment

 

12

 

315

 

(303)

 

(96.2)%

Support services

 

1,071

 

2,892

 

(1,821)

 

(63.0)%

Total cost of revenue

 

8,623

 

12,601

 

(3,978)

 

(31.6)%

Gross profit (loss)

 

697

 

(2,815)

 

3,512

 

(124.8)%

Operating expenses

 

 

 

 

 

 

 

 

Research and development

 

1,212

 

5,043

 

(3,831)

 

(76.0)%

Selling and marketing

 

2,275

 

4,809

 

(2,534)

 

(52.7)%

General and administrative

 

9,131

 

8,783

 

348

 

4.0%

Total operating expenses

 

12,618

 

18,635

 

(6,017)

 

(32.3)%

Loss from operations

 

(11,921)

 

(21,450)

 

9,529

 

(44.4)%

Interest expense

 

(1,070)

 

(3,897)

 

2,827

 

(72.5)%

Loss on fair value of warrants

 

(1,044)

 

(2,620)

 

1,576

 

(60.2)%

Loss on fair value of contingent earnout liabilities

 

 

(437)

 

437

 

(100.0)%

Loss on warrant cancellation

 

(11,357)

 

 

(11,357)

 

100.0%

Other income (expense), net

 

(11)

 

94

 

(105)

 

(111.7)%

Income (loss) before provision for income taxes

 

(25,403)

 

(28,310)

 

2,907

 

(10.3)%

Provision for income taxes

 

(8)

 

(4)

 

(4)

 

100.0%

Net income (loss)

 

$(25,411)

 

$(28,314)

 

$2,903

 

(10.3)%

 

Revenue

The following table presents the revenue disaggregated by products and service type, as well as the percentage of total revenue.

 

 

Three Months Ended March 31,

 

 

 

 

 

2025

 

2024

 

Change

 

%

 

(In thousands, except for percentages)

3D Printer sales

 

$7,523

 

80.7%

 

$7,660

 

78.3%

 

$(137)

 

(1.8)%

Recurring payment

 

 

 

470

 

4.8%

 

(470)

 

(100.0)%

Support services

 

1,790

 

19.2%

 

1,656

 

16.9%

 

134

 

8.1%

Other

 

7

 

0.1%

 

 

 

7

 

100.0%

Total Revenue

 

$9,320

 

100.0%

 

$9,786

 

100.0%

 

$(466)

 

(4.8)%

 

35


 

Total revenue for the three months ended March 31, 2025 and 2024 was $9.3 million and $9.8 million, respectively, a decrease of $0.5 million, or 4.8%.

3D Printer sales were $7.5 million and $7.7 million for the three months ended March 31, 2025 and 2024, respectively, a decrease of $0.2 million. The decrease in revenue was primarily attributed to the lower number of systems sold. The 3D Printer sales also included printed parts and consumables revenue.

Recurring Payment revenue, structured as an operating lease, was $0 for the three months ended March 31, 2025 and $0.5 million for the three months ended March 31, 2024. The decrease was primarily attributable to a revenue reduction related to fewer operating lease transactions.

Our Support Services revenue was $1.8 million and $1.7 million for the three months ended March 31, 2025 and 2024, respectively, a increase of $0.1 million. The increase in Support Services revenue was primarily due to services provided to customers as a result of increased installed base.

Other revenue was less than $0.1 million and $0 for the three months ended March 31, 2025 and 2024, respectively.

Cost of Revenue

The following table presents the Cost of Revenue disaggregated by product and service type, as well as the percentage of total cost of revenue.

 

 

Three Months Ended March 31,

 

 

 

 

 

2025

 

2024

 

Change

 

%

 

(In thousands, except for percentages)

Cost of Revenue

 

 

 

 

 

 

 

 

 

 

 

 

Cost of 3D Printers

 

$7,540

 

87.4%

 

$9,394

 

74.5%

 

$(1,854)

 

(19.7)%

Cost of Recurring Payment

 

12

 

0.1%

 

315

 

2.5%

 

(303)

 

(96.2)%

Cost of Support Services

 

1,071

 

12.5%

 

2,892

 

23.0%

 

(1,821)

 

(63.0)%

Total Cost of Revenue

 

$8,623

 

100.0%

 

$12,601

 

100.0%

 

$(3,978)

 

(31.6)%

 

Total cost of revenue for the three months ended March 31, 2025 and 2024 was $8.6 million and $12.6 million, respectively, a decrease of $4.0 million, or 31.6%.

Cost of 3D Printers was $7.5 million and $9.4 million for the three months ended March 31, 2025 and 2024, respectively. The decrease of $1.9 million was due to a decrease in number of systems sold for the three months ended March 31, 2025, compared to the three months ended March 31, 2024.

Cost of Recurring Payment was less than $0.1 million and $0.3 million for the three months ended March 31, 2025 and 2024, respectively. This decrease of $0.3 million was primarily due to a decrease in depreciation of the equipment on lease and allocable Cost of Support Services as a result of fewer 3D Printers in service in the three months ended March 31, 2025, compared to the three months March 31, 2024.

Cost of Support Services was $1.1 million and $2.9 million for the three months ended March 31, 2025 and 2024, respectively. Cost of Support Services decreased by $1.8 million, due to the fixed costs associated with field service engineering labor and overhead in March 31, 2025, compared to March 31, 2024.

In addition, field service engineering support cost has increased specifically with regard to increasing sales of Sapphire XC systems and introduction of the Sapphire 1MZ and Sapphire XC 1MZ systems in the field. We expect this to decrease on a per unit basis as the Sapphire XC, Sapphire 1MZ and Sapphire XC 1MZ system performance improves. We also expect our Cost of Support Services will increase with the delivery of more 3D Printer systems to customers.

Cost of revenue as a percentage of revenue was 92.5% and 128.8% for the three months ended March 31, 2025 and 2024, respectively. The decrease in the cost of revenue as a percentage of revenue was primarily driven by lower cost associated with raw materials and direct labor efficiency improvements.

We may experience increasing component costs from our suppliers due to international tarriffs and our current financial situation. We are currently unable to secure credit terms and volume discounts with our suppliers, causing us to pay a premium, in advance, or

36


 

source from alternate suppliers at unfavorable terms for our products. This has negatively impacted our cost of revenue and will continue to negatively impact our cost of revenue until our financial conditions improve and costs associated with tariffs ease.

Gross Profit and Gross Margin

Total gross profit (loss) was $0.7 million and $(2.8) million for the three months ended March 31, 2025 and 2024, respectively. As a percentage of revenue, the gross margin was 7.5% and (28.8)% for the three months ended March 31, 2025 and 2024, respectively. The increase in gross profit for the three months ended March 31, 2025 was primarily attributable to the lower cost associated with system revenue during the three months ended March 31, 2025, as compared to the three months ended March 31, 2024.

Our gross profit and gross margin are influenced by a number of factors, including:

Product mix of Sapphire, and Sapphire XC systems;
Average selling prices for our systems;
Trends in materials and shipping costs;
Production volumes that may impact factory overhead absorption;
System reliability performance; and
Impact of product mix changes, including new product introductions, and other factors, on our Cost of Support Services.

Due to the aforementioned trends in customer orders and component costs, our gross profit and gross margin have been and will continue to be negatively impacted until our financial conditions improve.

Research and Development Expenses

Research and development expenses were $1.2 million and $5.0 million for the three months ended March 31, 2025 and 2024, respectively, a decrease of $3.8 million. The decrease in research and development expenses was driven by a $2.8 million decrease in headcount, salaries and employee-related expenses, a decrease of $0.8 million in stock-based compensation, a decrease of $0.2 million in miscellaneous expenses.

We expect research and development costs to remain at similar levels for the remainder of 2025 due to the maturation of our Sapphire family of systems and certain investments in improvements current product line and to increase in the long term as we continue to invest in enhancing and advancing our portfolio of AM solutions.

Selling and Marketing Expenses

Selling and marketing expenses were $2.3 million and $4.8 million for the three months ended March 31, 2025 and 2024, respectively, a decrease of $2.5 million. The decrease was attributable to a decrease of $1.5 million in headcount, salaries and employee-related expenses, a $0.9 million decrease in stock-based compensation, and a $0.4 million decrease in marketing costs and initiatives.

We expect selling and marketing expenses to increase for the remainder of 2025 as we re-engage with key customers and drive RPS traction. During the remainder of 2025, we intend to continue our focus on certain markets that show strong attendance at additive manufacturing conferences to build product awareness.

General and Administrative Expenses

General and administrative expenses were $9.1 million and $8.8 million for the three months ended March 31, 2025 and 2024, respectively, an increase of $0.3 million. The increase was attributable to a $0.3 million increase in legal and other professional fees.

We expect general and administrative expenses to decrease as a result of savings from our reduction in force implemented in late 2024. We continue to focus on our company-wide initiatives to reduce operating costs for the remainder of 2025 as we continue to

37


 

reducing our general and administrative expenses through reducing our reliance on outside consultants, managing facility costs, negotiating with vendors for improved pricing and enterprise level efficiency improvements.

Interest Expense

Interest expense was $1.1 million and $3.9 million for the three months ended March 31, 2025 and 2024, respectively, due to the reduction in Senior Secured Notes and offset by the issuance of the Secured Secured Convertible Notes.

We expect our interest expense will continue to decrease as a result of our reduced debt.

Gain (loss) on Fair Value of Warrants

The change in fair value of warrants resulted in a loss of $1.0 and $2.6 million for the three months ended March 31, 2025 and 2024, respectively, and was related to the non-cash fair value change of the warrant liabilities driven by the relative change in our stock price.

Gain (loss) on Fair value of Contingent Earnout Liabilities

The change in fair value of the contingent earnout liability was $0 and $0.4 million for the three months ended March 31, 2025 and 2024, respectively, and was related to the non-cash fair value change of the earnout liabilities driven by the relative change in our stock price

Loss on Warrant Cancellation

Loss on warrant cancellation was $11.4 million and $0 for the three months ended March 31, 2025 and March 31, 2024 and related to the loss recognized in conjunction with the February 2025 Warrant Exchange transaction.

Other Income (Expense), Net

Other (expense) and income, net was less than ($0.01) million and less than $0.1 million for the three months ended March 31, 2025 and 2024, respectively.

Income Taxes

No provision for federal and state income taxes was recorded for both the three months ended March 31, 2025 and 2024 due to projected losses, and we maintained a full valuation allowance on the deferred tax assets as of March 31, 2025 and December 31, 2024.

We will continue to review our conclusions about the appropriate amount of the valuation allowance on a quarterly basis. If we were to generate profits in the remainder of 2025 and beyond, the U.S. valuation allowance position could be reversed in the foreseeable future. We expect a benefit to be recorded in the period the valuation allowance reversal is recorded and a higher effective tax rate in periods following the valuation allowance reversal.

Liquidity and Capital Resources

As of March 31, 2025, the Company had approximately $3.9 million in cash and short-term investments and $4.6 million in accounts receivable. Our business requires substantial amounts of cash for operating activities, including salaries and wages paid to our employees, component and sub-assembly purchases, general and administrative expenses, and others.

Our purchase commitments per terms and conditions with suppliers and vendors are cancellable in whole or in part prior to shipment. Purchase commitments (purchase orders) of $1.5 million for parts and assemblies are due upon receipt and will primarily be delivered throughout the remainder of 2025. If inventory is shipped, we will accrue a liability under accrued expenses. We have no other commitments and contingencies, except for the operating leases and the Secured Notes, the January Note, and the February Note. See Note 8, Leases, in the unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report for further discussion.

During the three months ended March 31, 2025, we experienced less revenue growth than expected due to our focus on high-value customers, resulting in a small decrease in system sales as compared to the first quarter in 2024. As of March 31, 2025, we do not have sufficient working capital to meet our financial needs for the twelve-month period following the filing date of these

38


 

unaudited condensed consolidated interim financial statements. As such, we believe that there is substantial doubt about our ability to continue as a going concern for the twelve-month period following the issuance of these unaudited condensed consolidated interim financial statements. See Note 1 Description of Business and Basis of Presentation—Going Concern, Financial Condition and Liquidity and Capital Resources in the unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report.

On December 9, 2024, Arrayed Notes Acquisition Corp., a subsidiary of Arrayed Additive, Inc. purchased the Senior Secured Notes from then Note holders.

On December 24, 2024, the Company and Arrayed Notes Acquisition Corp. (“Arrayed”) entered into a debt for equity exchange transaction where the Company issued 185,151,333 shares of the Company’s common stock, in exchange for the cancellation of $22,382,000.00 in principal amount of the Company’s Senior Secured Notes due 2026 plus $369,303.00 of accrued interest on the Notes. As of March 31, 2025, Arrayed held approximately $5.0 million in principal amount of the Notes, and was the owner of 95% of the Company’s issued and outstanding common stock.

On January 7, 2025, the Company issued the January Note, a Senior Secured Convertible Promissory Note in the principal amount of $5,000,000 to Thieneman Properties, LLC, an Indiana limited liability company. The Note is payable in full on April 7, 2025 in the amount of $5,750,000 and if not paid on or prior to such date, will continue to accrue interest at the same rate until paid. The Note may be prepaid in whole or in part at any time without penalty or premium and is convertible in the event of default into shares of the Company’s common stock, at a fixed conversion price of $1.56 per share. On April 7, 2025, the Company paid an interest payment of $750,000, covering the first three months of interest on the January Note.

On February 10, 2025, the Company issued the February Note, a Senior Secured Convertible Promissory Note in the principal amount of $10,000,000 to Thieneman Construction, Inc, an Indiana corporation, to be funded in two tranches of $5,000,000. The February Note bears interest at a rate of 30.0% per annum, is payable in full on the date that is six months from the date such tranche was funded, in the amount of $5,750,000 and if not paid on or prior to such date, will continue to accrue interest at the same rate until paid. The outstanding principal amount of the February Note is convertible upon the occurrence of the Company’s successful listing of shares of its common stock on a national securities exchange or the occurrence and during the continuation of an Event of Default, into Common Shares at a fixed conversion price of $1.00 per share.

We will need to engage in additional financings to fund our operations and satisfy our debt obligations in the near-term as well as to respond to business challenges and opportunities, including the need to repay the Secured Notes, provide working capital, continue to fund payroll for employees, improve our operating infrastructure, and continue to sustain operations. Accordingly, subject to our compliance with the covenants in the Secured Notes, to fund our operations, we will need to engage in equity or debt financings to secure additional funds, including seeking additional capital from public or private offerings of our equity or debt securities, electing to repay, restructure or refinance our existing indebtedness, or electing to borrow additional amounts under new credit lines or from other sources. We may also seek to raise additional capital, including from offerings of our equity or debt securities, on an opportunistic basis when we believe there are suitable opportunities for doing so.

Additionally, our recent and projected financial results, and the related conditions that raise substantial doubt about our ability to continue as a going concern, and general concerns among potential investors and creditors about our financial well-being, may make securing additional financing and cost cutting activities on commercially reasonable terms or in an amount sufficient to fund our operations for at least 12 months especially difficult.

More generally, our ability to meet our cash requirements depends on, among other things, our operating performance, competitive and industry developments, and financial market conditions, all of which are significantly affected by business, financial, economic, political, and other factors, many of which we may not be able to control or influence. To the extent that our actual operating results or other developments differ from our expectations, our liquidity will continue to be adversely affected.

Debt Facilities

As of March 31, 2025, our debt arrangements comprised the Secured Notes, the January Notes, and the February Notes, of which we had approximately $20.0 million aggregate principal amount outstanding as of March 31, 2025.

See our other debt facilities as described in the“Liquidity and Capital Resources” section above.

We do not hedge our exposure to changes in interest rates. A 10% change in interest rates would not have a material impact on annualized interest expense.

39


 

For more information, see Note 9, Debt, in the notes of the unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report.

Cash Flow Summary

The following table summarizes our cash flows for the nine months ended March 31, 2025 and 2024:

 

 

Three Months Ended
March 31,

 

 

 

2025

 

2024

 

Change

 

(In thousands)

 

Net cash used in operating activities

 

$(12,349)

 

$(20,523)

 

$8,174

Net cash provided by investing activities

 

$—

 

$3,493

 

$(3,493)

Net cash provided by financing activities

 

$15,000

 

$285

 

$14,715

 

Operating Activities

Net cash used in operating activities for the three months ended March 31, 2025 was $12.5 million, consisting primarily of a net loss of $25.4 million, non-cash loss of $18.4 million described below, and a decrease in net operating assets of $5.9 million. The cash used from net operating assets was comprised of a decrease from accounts payable of $1.0 million, a decrease from contract liabilities of $2.6 million, a decrease from other net operating assets of $1.9 million, a decrease from prepaid expenses of $3.4 million related to insurance and vendor prepayments, and a decrease from inventories of $2.0 million for Sapphire XC, Sapphire 1MZ and Sapphire XC 1MZ system production, offset by an increase from other assets of $1.0 million and an increase from accrued expenses and other current liabilities of $0.2 million. The noncash loss of $18.4 million primarily consisted of the loss on cancelation of warrants of $11.4 million, stock-based compensation expense of $4.1 million, and the loss on fair value of warrants of $1.0 million

Net cash used in operating activities for the three months ended March 31, 2024 was $20.5 million, consisting primarily of a net loss of $28.3 million, non-cash loss of $12.7 million described below, and a decrease in net operating assets of $4.9 million. The decrease in net operating assets was comprised of a decrease from accounts payable of $4.2 million, a decrease from contract liabilities of $0.4 million, a decrease from other net operating assets of $1.7 million, a decrease in accrued expenses and other current liabilities of $0.2 million and a decrease from inventories of $2.6 million for Sapphire XC, Sapphire 1MZ and Sapphire XC 1MZ system production, offset by an increase from accounts receivable of $2.1 million due to timing of customer payments, and an increase from prepaid expenses of $1.1 million related to insurance and vendor prepayments. The noncash loss of $12.7 million primarily consisted of the stock-based compensation expense of $5.1 million, depreciation and amortization of $4.6 million and the loss on fair value of warrants of $2.6 million.

We expect our cash used in operating activities to decrease, driven by our efforts to stabilize our working capital requirements through our expense reduction efforts and overall enterprise efficiency improvement programs.

 

Investing Activities

 

There was no cash provided by investing activities during the three months ended March 31, 2025.

 

Net cash provided by investing activities during the three months ended March 31, 2024 was $3.5 million, consisting of maturities of available-for-sale investment securities of $3.5 million.

We expect our capital expenditures to increase in 2025 compared to 2024 as we invest in printer capacity and related facilities for RPS.

Financing Activities

Net cash provided by financing activities during the three months ended March 31, 2025 was $15.0 million, consisting of proceeds of $15.0 million from the issuance of the January Note and the February Note.

 

Net cash provided by financing activities during the three months ended March 31, 2024 was $0.3 million, consisting of proceeds of $0.3 million from the issuance of common stock upon exercise of stock options.

We expect cash provided by financing activities to increase by issuing new equity or incurring new debt to continue operations, subject to our compliance with the covenants in the Secured Notes. Our future cash requirements and the adequacy of available funds

40


 

will depend on many factors, including our operating performance, competitive and industry developments, and financial market conditions.

Off-Balance Sheet Arrangements

As of March 31, 2025 and December 31, 2024, we did not have any off-balance sheet arrangements.

Recent Accounting Pronouncements

For a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects, if any, on Velo3D’s unaudited condensed consolidated interim financial statements, see Note 2, Summary of Significant Accounting Policies, in the notes to the unaudited condensed consolidated interim financial statements in this Quarterly Report.

Implications of Being an Emerging Growth Company

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can choose not to take advantage of the extended transition period and comply with the requirements that apply to non-emerging growth companies, and any such election to not take advantage of the extended transition period is irrevocable. We are an “emerging growth company” as defined in Section 2(a)(19) of the Securities Act of 1933, as amended (the "Securities Act") and have elected to take advantage of the benefits of this extended transition period.

We will elect to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public business entities and nonpublic business entities until the earlier of the date we (a) are no longer an emerging growth company or (b) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. This may make it difficult or impossible to compare our financial results with the financial results of another public company that is either not an emerging growth company or an emerging growth company that has chosen not to take advantage of the extended transition period exemptions because of the potential differences in accounting standards used. Please refer to Note 2. Summary of Significant Accounting Policies, of the unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report for the recent accounting pronouncements adopted and the recent accounting pronouncements not yet adopted for the three months ended March 31, 2025 and 2024.

We will remain an emerging growth company under the JOBS Act until the earliest of (a) December 31, 2025, (b) the last date of our fiscal year in which we have total annual gross revenue of at least $1.235 billion, (c) the last date of our fiscal year in which we are deemed to be a “large accelerated filer” under the rules of the SEC or (d) the date on which we have issued more than $1.0 billion in nonconvertible debt securities during the previous three years.

Implications of Being a Smaller Reporting Company

We are a “smaller reporting company” as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited consolidated financial statements.

We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We will remain a smaller reporting company and may take advantage of certain scaled disclosures available to smaller reporting companies until the last day of the fiscal year in which (a) the market value of our voting and nonvoting common stock held by non-affiliates equals or exceeds $250.0 million measured on the last business day of that year’s second fiscal quarter and (b) our annual revenue equals or exceeds $100.0 million during the most recently completed fiscal year or our voting and nonvoting common stock held by non-affiliates equals or exceeds $700.0 million measured on the last business day of that year’s second fiscal quarter.

Critical Accounting Policies and Significant Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our unaudited condensed consolidated interim financial statements, which have been prepared in accordance with U.S. GAAP. We evaluated the development and selection of our critical accounting policies and estimates and believe that the following involve a higher degree of judgement or complexity and are most significant to reporting our results of operations and financial position and are therefore discussed as critical. The following critical accounting policies reflect the significant estimates and judgements used in the preparation of our unaudited condensed consolidated interim financial statements. Actual results could differ materially from those estimates and assumptions, and those differences could be material to our unaudited condensed consolidated interim financial statements. We re-evaluate our

41


 

estimates on an ongoing basis. For more information, see Note 2, Summary of Significant Accounting Policies, included in the notes to the unaudited condensed consolidated interim financial statements in this Quarterly Report, and Critical Accounting Policies and Significant Estimates in Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2024.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We are a smaller reporting company as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). As a result, pursuant to Item 305(e) of Regulation S-K, we are not required to provide the information required by this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed by us in reports filed or submitted under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Our management, with participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of March 31, 2025. Based upon this evaluation our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2025, our disclosure controls and procedures were not effective due to the material weaknesses in internal control over financial reporting described below.

Material Weaknesses in Internal Control over Financial Reporting

As described Part II, Item 9A. “Controls and Procedures” of our Annual Report on Form 10-K for the year ended December 31, 2024, we identified material weaknesses in our internal control over financial reporting. These material weaknesses have not been remediated as of March 31, 2025. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim consolidated financial statements will not be prevented or detected on a timely basis. The material weaknesses are as follows:

We did not design and maintain an effective control environment commensurate with our financial reporting requirements. Specifically, we did not maintain a sufficient complement of personnel with an appropriate degree of internal controls and accounting knowledge, experience, and training commensurate with our accounting and financial reporting requirements. Additionally, the lack of a sufficient complement of personnel resulted in an inability to consistently establish appropriate authorities and responsibilities in pursuit of our financial reporting objectives, as demonstrated by, among other things, insufficient segregation of duties in our finance and accounting functions. This material weakness contributed to the following additional material weaknesses.
We did not design and maintain effective controls over the segregation of duties related to journal entries and account reconciliations. Specifically, certain personnel have the ability to both (i) create and post journal entries within our general ledger system and (ii) prepare and review account reconciliations.
We did not design and maintain effective controls over the accounting and disclosure for debt and equity instruments. Specifically, we did not design and maintain effective controls over the accounting for the issuance and extinguishment of convertible note arrangements, warrants, common stock, and the accounting for earnout liabilities.
We did not design and maintain effective controls over the accounting for inventory and related accounts. Specifically, we did not design and maintain effective controls over verifying the existence of inventory, the accuracy of purchases, manufacturing costs, and write-offs and the financial statement presentation of inventory and related accounts.
We did not design and maintain effective controls over the accounting for contract assets and liabilities. Specifically, we did not design and maintain effective controls over the accuracy and the financial statement presentation of contract assets and liabilities, including variable consideration.

42


 

We did not design and maintain effective controls over financial statement preparation, presentation and disclosure commensurate with our financial reporting requirements. Specifically, we did not design and maintain effective controls over the appropriate classification and presentation of accounts and disclosures in the consolidated financial statements.

These material weaknesses resulted in adjustments to accounts receivable, inventory, other current assets, current and non-current contract liabilities, accrued expenses and other current liabilities which were recorded prior to the issuance of the consolidated financial statements as of and for the years ended December 31, 2019, 2020 and 2021 and as of and for the interim periods ended September 30, 2021 and December 31, 2021. These material weaknesses also resulted in the revision of our consolidated financial statements for the year ended December 31, 2022 and as of and for the interim periods ended March 31, 2022, June 30, 2022, September 30, 2022, March 31, 2023, June 30, 2023, and September 30, 2023. Also, these material weaknesses resulted in an uncorrected misstatement to inventories and cost of revenue and adjustments to debt – current portion and long-term debt, other income, additional paid in capital, gain on fair value of warrants, interest expense, revenue and contract assets, and loss on debt extinguishment which were recorded prior to the issuance of the consolidated financial statements as of and for the year ended December 31, 2023 and accounts receivable and contract assets as of and for the interim period ended March 31, 2025. These material weaknesses also resulted in adjustments to interest expense, debt – current portion, additional paid-in capital, warrant liabilities, contingent earnout liabilities and gain (loss) on fair value of contingent earnout liabilities, which were recorded prior to the issuance of the unaudited condensed consolidated interim financial statements as of and for the interim period ended March 31, 2025. Additionally, these material weaknesses could result in a misstatement of substantially all of our accounts or disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.

We did not design and maintain effective controls over certain information technology (“IT”) general controls for information systems that are relevant to the preparation of our consolidated financial statements. Specifically, we did not design and maintain effective:
user access controls to ensure appropriate segregation of duties and that adequately restrict user and privileged access to financial applications, programs, and data to appropriate company personnel; and
program change management controls to ensure that information technology program and data changes affecting certain financial IT applications and underlying accounting records are identified, tested, authorized and implemented appropriately.

These IT deficiencies did not result in a misstatement to the consolidated financial statements, however, the deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of IT dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all consolidated financial statement accounts and disclosures that would not be prevented or detected. Accordingly, management has determined these deficiencies in the aggregate constitute a material weakness.

Remediation Measures for Remaining Material Weaknesses in Internal Control over Financial Reporting

We have taken measures to remediate the material weaknesses remaining as of March 31, 2025, including the following: hired additional accounting and IT personnel to bolster our reporting, technical accounting and IT capabilities; provided ongoing training for our personnel on accounting, financial reporting and internal control over financial reporting; engaged a third-party to assist in designing and implementing controls, including controls related to segregation of duties and IT general controls; designing and implementing controls to formalize roles and review responsibilities to align with our team’s skills and experience and designing and implementing controls over segregation of duties; and designing and implementing controls over the preparation and review of journal entries and account reconciliations. Additionally, we will need to hire and train additional accounting and IT personnel to further bolster our technical accounting and IT capabilities. We have also begun planning for measures to remediate the material weaknesses related to designing and implementing controls over accounting and disclosure for debt and equity instruments, the accounting for the issuance and extinguishment of convertible note arrangements, warrants and common stock; designing and implementing controls over the accounting for inventory and related accounts, the accuracy of inventory, purchases, manufacturing costs, and write-offs and the financial statement presentation of inventory and related accounts; designing and implementing controls over the accounting for contract assets and liabilities, the accuracy and the financial statement presentation and disclosure of contract assets and liabilities, including variable consideration; designing and implementing controls over controls over financial statement preparation, presentation and disclosure commensurate with our financial reporting requirements, the appropriate classification and presentation of accounts and disclosures in the consolidated financial statements; and designing and implementing IT general controls, including controls over the review and update of user access rights and privileges and program change management controls.

43


 

We are making progress toward the effectiveness of our internal control over financial reporting and disclosure controls and procedures. The measures that we are taking are subject to continued testing, ongoing senior management review, as well as audit committee oversight. We will not be able to conclude whether the measures we are taking will fully remediate these material weaknesses in our internal control over financial reporting until we have completed our remediation efforts and subsequent evaluation of their effectiveness. We may also conclude that additional measures may be required to remediate the material weaknesses in our internal control over financial reporting, which may necessitate additional implementation and evaluation time. We will continue to assess the effectiveness of our internal control over financial reporting and take steps to remediate the known material weaknesses expeditiously.

Changes in Internal Control over Financial Reporting

Other than as described above, there were no changes in internal control over financial reporting during the quarter ended March 31, 2025 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we may be involved in various disputes and litigation matters that arise in the ordinary course of business. We are currently not a party to any material legal proceedings.

Item 1A. RISK FACTORS

There are numerous factors that affect our business and results of operations, many of which are beyond our control. Refer to Item 1A in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which contains descriptions of significant risks that have the potential to affect our business, financial condition, results of operations, cash flows, strategies or prospects in a material and adverse manner. Except as set forth below, there have been no material changes to risk factors previously disclosed in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024.

Risks Related to Our Financial Position and Need for Additional Capital

There is substantial doubt about our ability to continue as a going concern, which is having a material adverse impact on our business.

As of March 31, 2025, the Company had approximately $3.9 million in cash and short-term investments and $4.7 million in accounts receivable. This amount is insufficient to satisfy the Company's short term obligations including accounts payable of $16.4 million and $21.7 million in Secured and Convertible Notes as of March 31, 2025.

As described in Note 1 Description of Business and Basis of Presentation—Going Concern, Financial Condition and Liquidity and Capital Resources in the notes to the unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report, we believe there is substantial doubt about our ability to continue as a going concern for the twelve-month period following the filing date of this Quarterly Report.

Our conclusion that there is substantial doubt about our ability to continue as a going concern may be viewed unfavorably by current and prospective investors, as well as by analysts and creditors. As a result, this conclusion may make it more difficult for us to raise the additional financing necessary to continue to operate our business and satisfy our obligations. In addition, this conclusion may make it more difficult for us to sell our products and meet our sales forecasts or retain employees, which may further impede our ability to raise additional financing. If we become unable to continue as a going concern, we may find it necessary to file a petition for reorganization under Title 11 of the U.S. Code in order to provide us additional time to identify an appropriate solution to our financial situation and implement a plan of reorganization aimed at improving our capital structure.

This conclusion has caused customers to delay 3D printer orders until our financial condition improves, resulting in delays in 3D printer sales and difficulty building our bookings and backlog pipeline. Additionally, due to our inability to satisfy our accounts payable obligations, we are unable to secure credit terms and volume discounts with our suppliers, causing us to have to pay a premium and/or in advance, for components of our products and/or source components from alternate suppliers at unfavorable terms. Further delaying payments to our suppliers may cause them to terminate our business relationship, or pursue legal action against our Company for amounts owed. The Company will need to consider and implement significant cost cutting measures, including further

44


 

reductions in force. These activities may limit our ability to conduct or grow our business, and may make retaining our employees more difficult, resulting in further employee attrition.

We expect to require additional capital to fund our operations in the near-term, and this capital might not be available on acceptable terms, if at all.

We expect that we will need to engage in additional financings to fund our operations and satisfy our substantial debt obligations in the near-term as well as to respond to business challenges and opportunities, including the need to repay our Secured Notes, provide working capital, continuing to fund payroll, develop new features or enhance our products, expand our manufacturing capacity, improve our operating infrastructure or acquire complementary businesses and technologies. Accordingly, subject to our compliance with the covenants in the Secured Notes, we need to engage in equity or debt financings to secure additional funds, including seeking additional capital from public or private offerings of our equity or debt securities, electing to repay, restructure or refinance our existing indebtedness, or electing to borrow additional amounts under new credit lines or from other sources. However, our recent and projected financial results, and the related conditions that raise substantial doubt about our ability to continue as a going concern, and general concerns among potential investors and creditors about our financial well-being may make taking such actions on commercially reasonable terms especially difficult.

If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of holders of our common stock. Any debt financing that we may secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. We may not be able to obtain additional financing on terms favorable to us, if at all. Our ability to raise additional capital may be adversely affected by external factors beyond our control, including changes in the political climate, geopolitical actions, changes in market interest rates or foreign exchange rates, market volatility in the trading prices for our common stock and other technology companies, a recession, depression, high inflation or other sustained adverse market event, and the outbreak of epidemic disease. If we are unable to obtain adequate financing or financing on terms satisfactory to us in the near term, we will not be able to continue operations. If we are otherwise unable to obtain additional financing, our ability to respond to business challenges and opportunities could be significantly impaired, and our business may be adversely affected and we may be required to liquidate and/or file for bankruptcy protection.

Risks Related to our Business and Industry

There is uncertainty regarding U.S. tariffs and support for existing treaty and trade relationships, and implementation of new legislative or regulatory policies by the U.S. government could impose additional costs on the Company, result in delayed timelines, or otherwise negatively impact the Company, which could have a material adverse impact on the Company’s business.

In early February 2025, the United States announced a 25% broad-based tariff on goods exported out of Canada into the United States, other than energy products, which would be subject to a 10% tariff. In response, the Canadian government announced that it would impose a 25% tariff on $155 billion of goods imported from the U.S. The United States also announced a 25% tariff on goods imported from Mexico and a 10% tariff on goods imported from China. Representatives of the U.S. government have also publicly stated that they are considering imposing tariffs on goods imported from other countries. The tariffs were enacted on March 4, 2025, however, subsequently paused until April 2, 2025 pending further negotiations. The situation remains fluid, and the duration and outcome of these tariff actions are uncertain. As a result, we are unable to predict the ultimate result and duration of any tariff actions by the U.S. government, or countermeasures that may be taken by other nations.

It remains unclear what additional actions, if any, will be taken by the U.S. or other governments with respect to international trade agreements, the imposition of tariffs on goods imported into the U.S., tax policy related to international commerce, increased export control, sanctions and investment restrictions, import or use of foreign communications equipment, or other trade matters. Although the ultimate scope and timing of any such tariffs is indeterminable, if implemented, they could have a material impact on our financial condition and results of operations. Furthermore, there is a risk that the tariffs imposed by the United States on other countries will trigger a broader global trade war which could have a material adverse effect on the U.S. and global economies.

45


 

Risks Related to Compliance Matters

We are subject to U.S. and other anti-corruption laws, trade controls, economic sanctions and similar laws and regulations. Our failure to comply with these laws and regulations could subject us to civil, criminal and administrative penalties and harm our reputation.

Doing business on a worldwide basis requires us to comply with the laws and regulations of the U.S. government and various foreign jurisdictions. These laws and regulations place restrictions on our operations, trade practices, partners and investments.

In particular, our operations are subject to U.S. and foreign anti-corruption and trade control laws and regulations, such as the FCPA and the Bribery Act, export controls and economic sanctions programs, including those administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”), the State Department’s Directorate of Defense Trade Controls (“DDTC”) and the Bureau of Industry and Security (“BIS”) of the Department of Commerce. As a result of doing business in foreign countries and with foreign customers, we are exposed to a heightened risk of violating anti-corruption and trade control laws and sanctions regulations. In February 2025, President Donald J. Trump issued an executive order directing the U.S. Department of Justice to pause enforcement of the FCPA and to issue new enforcement guidelines that take into consideration U.S. national security and the competitiveness of U.S. companies abroad. It is unclear how this presidential directive may affect our industry as a whole or our business in particular.

Notwithstanding President Trump’s recent executive order to suspend enforcement of the FCPA, as part of our business, we may deal with state-owned business enterprises, the employees of which are considered foreign officials for purposes of the FCPA’s prohibition on providing anything of value to foreign officials for the purposes of obtaining or retaining business or securing any improper business advantage. In addition, the provisions of the Bribery Act extend beyond bribery of foreign public officials and also apply to transactions with individuals that a government does not employ. Some of the international locations in which we operate lack a developed legal system and have higher than normal levels of corruption. Our continued expansion outside the U.S., primarily in Europe, South-East Asia and Oceania, and our development of new partnerships worldwide, could increase the risk of FCPA, OFAC or Bribery Act violations in the future.

As an exporter, we must comply with various laws and regulations relating to the export of products and technology from the U.S. and other countries having jurisdiction over our operations. In the United States, these laws include the International Traffic in Arms Regulations (“ITAR”) administered by the DDTC, the Export Administration Regulations (“EAR”) administered by the BIS and trade sanctions against embargoed countries and destinations administered by OFAC. The EAR governs products, parts, technology and software which present military or weapons proliferation concerns, so-called “dual use” items, and ITAR governs military items listed on the United States Munitions List. Prior to shipping certain items, we must obtain an export license or verify that license exemptions are available. Any failures to comply with these laws and regulations could result in fines, adverse publicity and restrictions on our ability to export our products, and repeat failures could carry more significant penalties.

Violations of anti-corruption and trade control laws and sanctions regulations are punishable by civil penalties, including fines, denial of export privileges, injunctions, asset seizures, debarment from government contracts and revocations or restrictions of licenses, as well as criminal fines and imprisonment and could harm our reputation, create negative shareholder sentiment and affect the value of our securities. We have established policies and procedures designed to assist our compliance with applicable U.S. and international anti-corruption and trade control laws and regulations, including the FCPA, the Bribery Act and trade controls and sanctions programs administered by OFAC, the DDTC and BIS, and have trained our employees to comply with these laws and regulations. However, there can be no assurance that all of our employees, consultants, agents or other associated persons will not take actions in violation of our policies and these laws and regulations. Additionally, there can be no assurance that our policies and procedures will effectively prevent us from violating these regulations in every transaction in which we may engage or provide a defense to any alleged violation. In particular, we may be held liable for the actions that our joint venture partners take inside or outside of the United States, even though our partners may not be subject to these laws. Such a violation, even if our policies prohibit it, could have an adverse effect on our reputation, business, financial condition and results of operations. In addition, various state and municipal governments, universities and other investors maintain prohibitions or restrictions on investments in companies that do business with sanctioned countries, persons and entities, which could adversely affect our reputation, business, financial condition and results of operations.

 

46


 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

During the three months ended March 31, 2025, no director or Section 16 officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

47


 

Item 6. Exhibits

 

Exhibit Number

 

Description

10.1

 

Senior Secured Convertible Promissory Note, dated as of January 7, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on January 10, 2025)

10.2

 

Secured Guaranty, dated as of January 7, 2025 by Velo3D, Inc. in favor of Thieneman Properties, LLC (incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K filed on January 10, 2025)

10.3

 

Offer Letter, dated as of January 8, 2025, by and between Velo3D, Inc. and Arun Jeldi (incorporated by reference to Exhibit 10.3 to the Company’s Form 8-K filed on January 10, 2025)

10.4

 

Senior Secured Convertible Promissory Note, dated as of February 10, 2025, between the Company and Thieneman Construction, Inc. (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on February 12, 2025)

10.5

 

Secured Guaranty, dated as of February 10, 2025, by Velo3D US, Inc. in favor of Thieneman Construction, Inc. (incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K filed on February 12, 2025)

10.6

 

Form of Exchange Agreement for the Highbridge Holders and the Anson Holders (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on February 24, 2025)

10.7

 

Form of Exchange Agreement, dated February 21, 2025, for the High Trail Holders(incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K filed on February 24, 2025)

10.8

 

Form of Lock-Up Agreement, dated February 21, 2025 (incorporated by reference to Exhibit 10.3 to the Company’s Form 8-K filed on February 24, 2025)

31.1**

 

Certification of the Chief Executive Officer required by Rule 13a-14(a) or rule 15d-14(a)

31.2**

 

Certification of the Chief Financial Officer required by Rule 13a-14(a) or rule 15d-14(a)

32.1*

 

Certification of the Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350

32.2*

 

Certification of the Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350

101.INS

 

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document

101.SCH

 

Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

* Furnished herewith. This certification is not deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.

** Filed herewith.

† Portions of this exhibit (indicated with markouts) have been redacted in accordance with Item 601(b)(10)(iv).

48


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, in the City of Fremont, State of California.

 

 

VELO3D, INC.

 

 

 

Date: May 15, 2025

By:

/s/ Hull Xu

 

Name:

Hull Xu

 

Title:

Chief Financial Officer, Principal Financial Officer and Authorized Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

49